S.No. Product Name Composition Ph Strength
1 A Balanced Protein Supplement Fortified with Essential Vitamins , Minerals & DHA Each 30g contains: Protein Hydrolysate 20% DHA 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients IP IP IP IP IP USP IP USP USP IP IP 5 g 25 mg 0.5 mg 1 mcg 100 IU 0.3 mg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
2 Abalanced Protein Supplement Fortified with Essential Vitamins & Minerals Each 30gmpowder Contains Whey Protein 30% Docosa HexaenoicAcid 10 % Pyridoxine Hydrochloride Cyanocobalamin Vitamin D3 Folic Acid Niacinamide Calcium (as Dibasic Calcium Phosphate Dihydrate IP) Manganese Sulphate Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Magnesium Oxide Cupric Sulphate Chromium (as Chromium Chloride USP) Selenium Dioxide Monohydrate Potassium Chloride Sodium Chloride Iodine (as Potassium Iodide IP) Excipients IP IP IP IP IP USP IP USP USP IP IP 10 g 25 mg 0.5 mg 1 mcg 100 IU 300 mcg 15 mg 200 mg 1.5 mcg 1.5 mg 10 mg 4 mg 2.5 mg 25 mcg 20 mcg 5 mg 33 mg 100 mcg q.s.
3 Acebrophylline & Acetylcysteine Tablets Each film coated Tablet Contains: Acebrophylline Acetylcysteine Excipients Approved colour used. BP 100mg 600mg q.s.
4 Acebrophylline & N- Acetyl L- Cysteine Tablets Each film coated Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used BP 100mg 600mg q.s.
5 Acebrophylline & N- Acetyl L- Cysteine Tablets Each film coated Bilayered Tablet Contains: Acebrophylline N- Acetyl L-Cysteine Excipients Approved colour used BP 100mg 600mg q.s.
6 Acebrophylline Sustained Release Tablets Each film coated sustained release Tablet contains : Acebrophylline Excipients Approved colour used 200mg q.s.
7 Aceclofenac & DrotaverineTablets Each Film Coated Tablet Contains: Aceclofenac Drotaverine Hydrochloride Excipients Colour : Approved Colour Used IP IP 100mg 80mg q.s.
8 Aceclofenac & Paracetamol Tablets Each Uncoated Tablets Contains: Aceclofenac Paracetamol Excipients Approved colour used (Aceclofenac ParacetamolFinished Product and Raw Material in Amendent 2024) IP IP 100 mg 325 mg q.s.
9 Aceclofenac & Serratiopeptidase Tablets Each filmcoated tablet contain: Aceclofenac Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved colour used IP IP 100 mg 10 mg q.s.
10 Aceclofenac & Serratiopeptidase Tablets Each film coated Tablet Contains: Aceclofenac Serratiopeptidase (Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used. IP IP 100mg 15mg q.s.
11 Aceclofenac & Thiocolchicoside Tablets Each Film Coated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : Approved Colour Used IP IP 100mg 4mg q.s.
12 Aceclofenac & Thiocolchicoside Tablets Each Film Coated Tablet Contains: Aceclofenac Thiocolchicoside Excipients Colour : Approved Colour Used IP IP 100mg 8mg q.s.
13 Aceclofenac along with Linseed oil, Menthol, Methyl Salicylate & Capsaicin Composition :- Aceclofenac Linseed Oil Menthol Methyl Salicyclate Capsaicin Banzyl Alcohol (as Preservative) Gel base IP BP IP IP USP IP 1.5%w/w 3%w/w 5%w/w 10%w/w 0.010%w/w 1%w/w q.s.
14 Aceclofenac Sustained Release Tablets Each Film Coated Tablet Contains : Aceclofenac (As Sustained Release) Excipients Colour : Approved Colour Used IP 200mg q.s.
15 Aceclofenac Tablets Each film coated Tablets Contains : Aceclofenac Excipients Approved colour used. IP 100mg q.s.
16 Aceclofenac, Paracetamol, Caffeine, Phenylephrine HCL & Cetirizine Hydrochloride Tablets Each uncoated tablet contains: Aceclofenac Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Caffeine(Anhydrous) Excipients Approved colour used IP IP IP IP IP 100 mg 325 mg 5 mg 10 mg 25 mg q.s.
17 Aceclofenac, Paracetamol & Chlorzoxazone Tablet Each Film Coated Tablet Contains Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used IP IP USP q.s. 100 mg 325 mg 250 mg
18 Aceclofenac, Paracetamol & Chlorzoxazone Tablets Each Film coated Tablet Contains: Aceclofenac Paracetamol Chlorzoxazone Excipients Approved colour used IP IP USP 100mg 325mg 500mg q.s.
19 Aceclofenac, Paracetamol & Chymotrypsin Tablets Each Film coated Tablets Contains: Aceclofenac Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymaticactivity (Supplied bya purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used IP IP 100 mg 325 mg 50000 AU q.s.
20 Aceclofenac, Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used. IP IP IP 100mg 325mg 15mg q.s.
21 Aceclofenac, Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Aceclofenac Paracetamol Serratiopeptidase (Eq. to 20,000 Serratiopeptidase units)Excipients Approved Colour Used. IP IP IP 100mg 325mg 10mg q.s
22 Aceclofenac, Paracetamol & Thiocolchicoside Tablet Each Film Coated Tablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used IP IP q.s. 100 mg 325 mg 4 mg
23 Aceclofenac, Paracetamol & Thiocolchicoside Tablet Each Film Coated Tablet Contains Aceclofenac Paracetamol Thiocolchicoside Excipients Approved colour used IP IP q.s. 100 mg 325 mg 8 mg q.s.
24 Aceclofenac, Paracetamol Tablets Each Film coated Tablets Contains: Aceclofenac Paracetamol Excipients Approved colour used IP IP 100 mg 325 mg q.s.
25 Aceclofenac, Paracetamol, Phenylephrine HCL, Cetirizine HCL & Caffeine Tablets Eachuncoated tablet contains: Aceclofenac Paracetamol Phenylephrine HCL Cetirizine HCL CaffeineAnhydrous IP IP IP IP IP 100mg 325mg 10mg 5mg 25mg q.s.
26 Aciclovir Dispersible Tablet IP Each uncoated tablet contains: Aciclovir Excipients Approved colour used IP 800 mg
27 Aciclovir Tablet IP Each uncoated tablet contain: Aciclovir Excipients Approved colour used IP 800 mg q.s.
28 Acyclovir Dispersible Tablets IP Each uncoated Tablets Contains: Acyclovir Excipients Approved colour used IP 400 mg q.s.
29 Albendazole Oral Suspension IP Each 5ml contains: Albendazole Excipients Approved colour used IP 200mg q.s.
30 Albendazole & Ivermectin Tablet Each Uncoated tablet contains: Albendazole Ivermectin Excipients Colour :- Approved colour used IP IP 400mg 6mg q.s.
31 Albendazole Tablet IP Each Uncoated Chewable Tablet Contains:- Albendazole Excipients Colour:- Approved Colour used IP 400mg q.s.
32 Allopurinol Tablets IP Each uncoated tablets contains: Allopurinol Excipients Approved colour used IP 100 mg q.s.
33 Allopurinol Tablets IP Each uncoated tablets contains: Allopurinol Excipients Approved colour used IP 300 mg q.s.
34 Alprazolam Tablets IP Each uncoated tablet contains: Alprazolam Excipients Approved colour used IP 0.25 mg q.s
35 Alprazolam Tablets IP Each uncoated tablet contains: Alprazolam Excipients Approved colour used IP 0.5 mg q.s
36 Ambroxol Hydrochloride (SR)& Levocetirizine hydrochloride Tablets Each Film coated Tablet Contains:- Ambroxol Hydrochloride (As sustained Release) Levocetirizinehydrochloride Excipients Approved colour used IP IP 75 mg 5mg q.s.
37 Ambroxol Hydrochloride & Cetirizine Hydrochloride Syrup Each 5ml contains : Ambroxol Hydrochloride Cetirizine Hydrochloride In a Flavoured SyrupyBase. Approved colour used IP IP 30mg 5mg q.s.
38 Ambroxol Hydrochloride, Terbutaline Sulphate & Guaiphenesin oral Drops Each ml(Approx. 20drops) contains : Ambroxol Hydrochloride Terbutaline Sulphate Guaiphenesin In a flavoured syrupyBase. Approved colour used. IP IP IP 7.5mg 0.5mg 12.5mg q.s.
39 Amisulpride Tablets IP Each Uncoated Tablet Contains: Amisulpride Excipients Approved colour used. IP 100mg q.s.
40 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 10 mg q.s.
41 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 25 mg q.s.
42 Amitriptyline Hydrochloride Tablets IP Each film coated tablet contains:- Amitriptyline Hydrochloride Excipients Colour:- Approved Colour used IP 50 mg q.s.
43 Amlodipine & Atenolol Tablets Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Atenolol Excipients Colour:- Approved colour used IP IP 5 mg 50 mg q.s.
44 AmlodipineTablets IP Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used IP 5 mg q.s
45 AmlodipineTablets IP Each uncoated tablet contains:- Amlodipine Besylate Equivalent to Amlodipine Excipients Colour : Approved Coloured Used IP 10 mg q.s
46 AmlodipineTablets IP Each uncoated Tablet contains: Amlodipine Besylate Equ. To Amlodipine Excipients Approved colour used. IP 2.5mg q.s.
47 Artemether & Lumifantrine Tablets Each uncoated Tablets Contains: Artemether Lumifantrine Excipients Approved colour used IP 80 mg 480 mg q.s.
48 Ascorbic Acid (Vitamin C ), Sodium Ascorbate & Zinc Chewable Tablets Each uncoated Tablet Contains: Ascorbic Acid Sodium Ascorbate Equ. To Ascorbicacid Zinc Excipients Approved Colour Used IP IP 100mg 450mg 400mg 5mg q.s
49 Ascorbicacid Tablet IP Each Uncoated Chewable Tablet Contains Ascorbic acid Excipients Colour : Approved Colour Used IP 500mg
50 Atenolol Tablets IP Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used IP 50mg q.s
51 Atenolol Tablets IP Each Uncoated Tablet Contains: Atenolol Excipients Colour : Approved Coloured Used IP 100mg q.s
52 Atorvastatin & FinofibrateTablets Each filmcoated tablet contain Atorvastin Calcium Eq.to Atorvastin Finofibrate Excipients Approved colour used IP IP 10 mg 160 mg q.s.
53 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. to Atorvastatin Excipients Colour:- Approved colour used IP 10 mg q.s.
54 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. to Atorvastatin Excipients Colour:- Approved colour used IP 20 mg q.s.
55 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. to Atorvastatin Excipients Colour:- Approved colour used IP 40 mg q.s.
56 Atorvastatin Tablets IP Each film coated tablet contains:- Atorvastatin Calcium Eq. to Atorvastatin Excipients Colour:- Approved colour used IP 80 mg q.s.
57 Azathioprine Tablets IP Each uncoated tablet contains: Azathioprine Excipients Approved colour used. IP 50mg q.s.
58 Azithromycin & Lacticacid Bacillus Tablet Each film coated tablet contains: Azithromycin Dihydrate Equ. to Azithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used IP 250mg 60 million spores q.s
59 Azithromycin & Lacticacid Bacillus Tablet Each film coated tablet contains: Azithromycin Dihydrate Equ. to Azithromycin Anhydrous Lactic acid Bacillus Excipients Approved colour used IP 500mg 60 million spores q.s
60 Azithromycin Dispersible Tablet Each uncoated dispersible Tablet Contains : Azithromycin Dihydrate Equ. To Azithromycin anhydrousExcipients Colour : Approved Coloured Used IP 100mg
61 Azithromycin Tablet IP Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used IP 250 mg q.s.
62 Azithromycin Tablet IP Each film coated tablet contains: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Excipients Approved colour used IP 500 mg q.s.
63 Baclofen Tablets IP Each uncoated tablet contains: Baclofen Excipients Approved colour used. IP . 10mg q.s.
64 Baclofen Tablets IP Each uncoated tablet contains:- Baclofen Excipients Approved colour used. IP 25mg q.s
65 Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream Composition: Beclomethasone Dipropionate Phenylephrine Hydrochloride Lignocaine Hydrochloride Preservative Chlorocresole Aqueous cream base IP IP IP IP 0.025%w/w 0.10% w/w 2.50% w/w 0.1% w/w q.s.
66 Betahistine Tablet (SR) IP Each uncoated sustainedrelease tablet contain: Betahistine Hydrochloride Excipients Approved colour used IP 24 mg q.s.
67 Betahistine Tablet IP Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used IP 8mg q.s.
68 Betahistine Tablet IP Each Uncoated Tablet Contains:- Betahistine hydrochloride Excipients Approved colour used IP 16 mg q.s.
69 Betahistine Tablets IP Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used IP 8 mg q.s.
70 Betahistine Tablets IP Each uncoated tablets contains: Betahistine Hydrochloride Excipients Approved colour used IP 16 mg q.s.
71 Betahistine Tablets IP Each uncoated Tablet contains: Betahistine Hydrochloride Excipients Approved colour used. IP 24mg q.s.
72 Betamethasone Tablets IP Each uncoated tablet contains:- Betamethasone Excipients Colour : Approved Coloured Used IP 0.5mg q.s.
73 Bilastine & Montelukast Tablets Each Film Coated bilayered tablet Contains: Montelukast Sodium eq. to Montelukast Bilastine Excipients Approved colour used. IP 10mg 20mg q.s.
74 Bilastine Tablets Each Film Coated Tablet Contains: Bilastine Excipients Approved colour used 20mg q.s.
75 Biotin & FolicAcid Tablets Each film coated Tablet contains: Biotin Folic Acid Excipients Approved Colour used USP IP 5mg 5mg q.s
76 Biotin Tablets USP Each Film coated Tablet Contains : Biotin Excipients Approved colour used USP 10mg q.s.
77 Bisacodyl Tablets IP Each enteric coated tablet contains: Bisacodyl Excipients Approved colour used IP 5mg q.s.
78 Bisoprolol Fumarate Tablets Each film coated tablet contains: Bisoprolol Fumarate Excipients Approved colour used. IP 2.5mg q.s.
79 Bisoprolol Fumerate Tablets Each film coated tablet contains: Bisoprolol Fumerate Excipients Approved colour used. IP 5mg q.s.
80 Calcium & Vitamin D3 Tablets IP Each Film coated Tablet Contains : Calcium Carbonate Equ. toElemental Calcium Vitamin D3 Excipients Approved Colour Used. IP IP 500mg 250IU q.s.
81 Calcium Carbonate & Vitamin D3 Tablets Each film coated Tablet contains: Calcium Carbonate (Derived from an organicsource oyster shell) Equ. To Elemental Calcium Vitamin D3 "Excipients Approved colour used." IP IP 1250mg 500mg 500IU q.s.
82 Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets Each Film Coated Tablet Contains : Calcium Carbonate( from Oyster shell) Equ. To Elemental Calcium Vitamin D3 Methylcobalamin L- Methylfolate Calcium Pyridoxal-5- Phosphate Excipients Approved colour used. IP IP 1250mg 500mg 2000IU 1500mcg 1mg 20mg q.s.
83 Calcium Citrate Maleate, Calcitriol , Folic Acid , Zinc & Vitamin K2-7 Tablets Each Film Coated Tablet Contains: Calcium Citrate Maleate Equ. ToElemental CalciumCalcitriol Folic Acid Zinc Sulphate Monohydrate Equ. To Zinc Vitamin K2-7 Excipients Approved colour used IP IP IP 250mg 0.25mcg 100mcg 7.5mg 50mcg q.s.
84 Calcium Citrate Maleate, Methylcobalamin, Vitamin D3, Vitamin K2-7, Magnesium Oxide & Zinc Oxide Tablets Each film coated tablet contains: Calcium Citrate Maleate Methylcobalamin Vitamin D3 Vitamin k2-7 Zinc Oxide Magnesium Oxide Excipients Approved colour used IP IP IP IP 1250mg 1500mcg 1000IU 90mcg 15mg 50mg q.s.
85 Calcium Citrate Maleate& Vitamin D3 Tablets Each film coated Tablet Contains: Calcium Citrate Maleate Equ. ToElemental CalciumVitamin D3 Excipients Approved colour used USP IP 1250mg 250mg 450IU q.s.
86 Calcium Citrate, Calcitriol , Zinc & Manganese Tablets Each film coated tablet contains: Calcium Citrate Calcitriol Zinc Sulphate Monohydrate Eq. to elemental Zinc Manganese (as Manganese Sulphate) Excipients Approved colour used. USP BP IP IP 1000 mg 0.25 mcg 7.5 mg 40 mg q.s.
87 Calcium Citrate, Magnesium, Zinc With Vitamin D3 Tablets Each film coated Tablet Contains: Calcium Citrate Magnesium Hydroxide Zinc Sulphate Monohydrate Equ. to Elemental Zinc Vitamin D3 Excipients Approved Colour Used. USP IP IP IP 1000mg 100mg 4mg 200IU q.s.
88 Calcium Orotate & Vitamin D3 Tablets Each film coated tablet contains: Calcium Orotate Vitamin D3 (Stabilized) Excipients Approved colour used. Appropriate overages of vitamin added to compensate the loss on storage. IP 740mg 1000 IU q.s.
89 Calcium Pantothenate Tablets I.P. 200mg Each film coated tablet contains: D-Calcium Pantothenate Excipients Approved colour used. IP 200mg q.s.
90 Calcium,VitaminD3, Methylcobalamin,L- Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets Each film coated tablet contains: Calcium Carbonate eq.to Elemental Calcium Vitamin D3 Mecobalamin (Methylcobalamin) L-Methylfolate calcium Pyridoxal-5-Phosphate Excipients Approved colour used. IP IP IP 1250mg 500mg 2000 I.U. 1500mcg 1mg 20mg q.s.
91 Carbamazepine Tablets IP Each uncoated tablet contains:- Carbamazepine Excipients Colour:- Approved Colour used IP 200 mg q.s.
92 Carbimazole Tablets IP Each Film coated Tablet Contains : Carbimazole Excipients Approved colour used IP 5mg q.s.
93 Carisoprodol Tablets IP Each Uncoated tablet contains:- Carisoprodol Excipients Colour:- Approved Colour used IP 350 mg q.s
94 Carvedilol Tablets IP Each film coated Tablet contains: Carvedilol Excipients Approved colour used IP 3.125mg q.s.
95 Carvedilol Tablets IP Each uncoated Tablet Contains: Carvedilol Excipients Approved colour used IP 12.5mg q.s.
96 Carvedilol Tablets IP Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used IP 6.25mg q.s.
97 Carvedilol Tablets IP Each Uncoated Tablet contains: Carvedilol Excipients Approved colour used IP 3.125mg q.s.
98 Cetirizine Dihydrochloride, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup Each 5ml contains : Dextromethorphan Hydrobromide Cetirizine Dihydrochloride Phenylephrine Hydrochloride In a flavoured SyrupyBase Approved colour Used IP IP IP 10mg 5mg 5mg q.s.
99 Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets Each film coated tablet contains: Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. IP IP 5mg 60mg q.s.
100 Cetirizine Hydrochloride Tablets IP Each uncoated tablet contains:- Cetirizine Hydrochloride Excipients Colour:- Approved Colour used IP 10 mg q.s.
101 Chlordiazepoxide & Clidinium Bromide Tablet Each Film Coated tablet contains Chlordiazepoxide Clidinium Bromide Excipients Approved Colour used IP IP 5mg 2.5mg q.s
102 Chlorpheniramine Maleate tablet IP Each Uncoated Tablet Contains: Chlorpheniramine Maleate Equ. To Chlorpheniramine Excipients IP 4mg q.s.
103 Chlorpromazine Hydrochloride Tablets IP Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used IP 50 mg q.s.
104 Chlorpromazine Hydrochloride Tablets IP Each film coated tablet contains:- Chlorpromazine Hydrochloride Excipients Colour:- Approved Colour used IP 100 mg q.s.
105 Chlorpromazine Hydrochloride Tablets IP Each film coated Tablet Contains: Chlorpromazine Hydrochloride Excipients Approved colour used. IP 50mg q.s.
106 Chlorzoxazone, Diclofenac Potassium, Paracetamol Each film coated tablet contains: Chlorzoxazone Diclofenac Potassium Paracetamol Excipients Approved colour used. USP BP IP 250mg 50mg 325mg q.s.
107 Cholecalciferol oral solution USP Each ml Contains: Cholecalciferol (Vitamin D3) In a pleasantlyflavoured palatable Base Approved Colour used. IP 400IU q.s.
108 Cholecalciferol Tablet IP Each uncoated chewable tablet contains Cholecalciferol (Stabilized) Excipients Colour :- Approved colour used IP 60000IU q.s.
109 Cholecalciferol, Ferrous Ascorbate, Folic Acid & Cyanocobalamin Tablets Each film coated Tablet Contains: Cholecalciferol Ferrous Ascorbate Equ. ToElemental IronFolic Acid Cyanocobalamin Excipients Approved colour used IP IP IP 1000IU 100mg 1mg 7.5mcg q.s.
110 Cilnidipine Tablet Each film coated tablet contains Cilnidipine Excipients Colour :- Approved Colour Used IP 10mg q.s
111 Cilnidipine Tablets IP Each film coated tablet contains: Cilnidipine Excipients Approved colour used. IP 5mg q.s.
112 Cilnidipine Tablets IP Each film coated tablet contains: Cilnidipine Excipients Approved colour used. IP 5mg q.s.
113 CilnidipineTablets IP Each film coated Tablet contains: Cilnidipine Excipients Approved colour used. IP 20mg q.s.
114 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved colour used. IP 50mg q.s.
115 Cilostazol Tablets IP Each uncoated tablet contains: Cilostazol Excipients Approved colour used. IP 100mg q.s.
116 Cinnarizine (SR)Tablet IP Each uncoatedtablet contain: Cinnarizine (As Sustained Release) Excipients Approved colour used IP 75 mg q.s.
117 Cinnarizine and Dimenhydrinate Tablets Each uncoated Tablet contains: Cinnarizine Dimenhydrinate Excipients Approved Colour used IP BP 20mg 40mg q.s
118 Cinnarizine Tablet IP Each uncoated tablet contain: Cinnarizine Excipients Approved colour used IP 25 mg q.s.
119 Cinnarizine Tablets IP Each uncoated Tablet contains Cinnarizine Excipients Approved Coloured used IP 75mg q.s
120 Cinnarizineand Domperidone Tablets Each uncoated Tablets Contains: Cinnarizine Domperidone Excipients Approved colour used IP IP 20 mg 15 mg q.s.
121 Ciprofloxacin and Tinidazole Tablets Each film coated Tablet contains: Ciprofloxacin Hydrochloride Equ. To Ciprofloxacin Tinidazole Excipients Approved colour used IP IP 250mg 300mg q.s
122 Ciprofloxacin Tablets IP Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:- Approved colour used IP 250 mg q.s.
123 Ciprofloxacin Tablets IP Each film coated tablet contains:- Ciprofloxacin Hydrochloride Eq. tociprofloxacin Excipients Colour:- Approved colour used IP 500 mg q.s.
124 Citicoline & PiracetamTablets Each Film coated Tablets Contains: Piracetam Citicoline sodium Equivalent to Citicoline Excipients Approved colour used IP IP 800 mg 500 mg q.s.
125 Citicoline Tablets Each Film coated Tablets Contains: Citicoline sodium Equivalent to Citicoline Excipients Approved colour used IP 500 mg q.s.
126 Clarithromycin Tablet IP Each film coated tablet Contains :- Clarithromycin Excipients Colour :- Approved colour used IP 250mg q.s.
127 Clarithromycin Tablet IP Each film coatedtablet contain: Clarithromycin Excipients Approved colour used IP 500 mg q.s
128 Clomifene Tablets IP Each uncoated tablet contains: Clomifene Citrate Excipients Approved colour used. IP 50mg q.s.
129 Clomiphene Citrate Tablets IP Each Uncoated Tablet Contains: Clomiphene Citrate Excipients IP 50mg q.s.
130 Clomiphene Tablet IP Each uncoated Tablet Contains :- Clomiphene Citrate Excipients Colour :- Approved colour used IP 50mg q.s
131 Clonazepam Tablet IP Each uncoated Tablet contains: Clonazepam Excipients Approved colour used IP 0.25mg q.s
132 Clonazepam Tablet IP Each uncoated Tablet contains: Clonazepam Excipients Approved colour used IP 0.5mg q.s
133 Clopidogrel Bisulphate Tablet Each film coated Tablet Contains: Clopidogrel Bisulphate Equ. toClopidogrel Excipients Colour : Approved Coloured Used IP 75mg q.s
134 Combikit of Azithromycin Tablet IP, Fluconazole Tablet IP & Secnidazole Tablet IP Each Combikit Contain: q) Azithromycin Tablet IP (1 Tablet)Each film coated tablet contain: Azithromycin Dihydrate Equivalent to Azithromycin anhydrous Approved colour used B) FluconazoleTablet IP (1 Tablet) Each uncoated tablet contain: Fluconazole Approved colour used C) SecnidazoleTablet IP(2Tablet) Each film coated tablet contain: Secnidazole Approved colour used IP IP IP 1 gm 150 mg 1 gm
135 Cyproheptadine Hydrochloride Tablet IP Each uncoated tablet contains : - Cyproheptadine Hydrochloride (as anhydrous) Excipients Colour : Approved Colour Used IP 4mg q.s
136 Cyproheptadine Tablet IP Each uncoated tablet contains: Cyproheptadine Hydrochloride (Anhydrous) Excipients Approved colour used IP 4 mg
137 Dapagliflozin & Metformin HCl (ER) Tablets Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used IP 10mg 1000mg q.s.
138 Dapagliflozin 10mg & Metformin HCl (ER) 500mg Tablets Each film coated Tablet Contains : Dapagliflozin Propanedial Monohydrate Equ. To Dapagliflozin Metformin Hydrochloride (as Extended Release) Excipients Approved colour used IP 10mg 500mg q.s.
139 Dapagliflozin Tablets Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used 5 mg q.s
140 Dapagliflozin Tablets Each film coated tablet contain: Dapagliflozin propanediol monohydrate Eq. to Dapagliflozin Excipients Approved colour used 10 mg q.s
141 Dapoxetine Tablets IP Each film coated tablet contains: Dapoxetine Hydrochloride Equ. To Dapoxetine Excipients Approved colour used IP 30 mg q.s
142 Dapoxetine Tablets IP Each film coated tablet contains: Dapoxetine Hydrochloride Equ. To Dapoxetine Excipients Approved colour used IP 60 mg q.s
143 Deflazacort Tablet Each uncoated tablet contain: Deflazacort Excipients Approved colour used 30 mg q.s.
144 Deflazacort Tablets Each Uncoated Tablet Contains: Deflazacort Excipients Approved Colour used 18mg q.s
145 Deflazacort Tablets Each uncoated tablet contains: Deflazacort Excipients Colour:- Approved colour used IP 12 mg q.s.
146 Desloratadine Tablet Each film coated Tablet Contains:- Desloratadine Excipients Approved colour used BP 5 mg q.s.
147 Dexamethasone Tablets IP Each uncoated tablet contains:- Dexamethasone Excipients Colour : Approved Coloured Used IP 0.5 mg q.s.
148 Dexketoprofen Tablet Each film coated Tablet Contains: Dexketoprofen trometamol Equ. To Dexketoprofen Excipients Colour : Approved Coloured Used 25mg q.s
149 Dextromethorphan HBR, Chlorpheniramine Maleate, Phenylephrine HCL Tablets Each uncoated tablet Contains: Dextromethorphan Hydrobromide Chlorpheniramine Maleate Phenylephrine Hydrochloride Excipients Approved colour used IP IP IP 10 mg 2 mg 5 mg q.s.
150 Dextromethorphan HBR, Bromhexine HCL & Phenylephrine HCL Syrup Each 5 ml Contains: Dextromethorphan Hydrobromide Bromhexine Hydrochloride Phenylephrine Hydrochloride In a flavoured syrupybase Approved colour base IP IP IP 5 mg 4 mg 5 mg q.s.
151 Dextromethorphan Hydrobromide, Phenylephrine hydrochloride & Chlorpheniramine Maleate Tablets Each uncoated tablet contains : Dextromethorphan Hydrobromide Phenylephrine Hydrochloride Chlorpheniramine Maleate Excipients IP IP IP 10mg 5mg 2mg q.s
152 Diacerein , Glucosamine & Methylsulfonylmet hane Tablets Each film coated tablets contains: Diacerein Glucosamine Sulphate potassium chloride Eq.to glucosamine Methylsulfonylmethane Excipients Approved colour used IP USP USP 50mg 750mg 446mg 250mg
153 Diclofenac & TolperisoneTablets Each uncoated sustained releaseTablet contains: Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used IP 450mg 100mg q.s.
154 Diclofenac Paracetamol & Chlorzoxazone Tablets Each uncoated tablet contains:- Paracetamol Diclofenac Potassium Chlorzoxazone Excipients Colour:- Approved colour used IP BP USP 325 mg 50 mg 250mg q.s.
155 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used. BP IP IP 50mg 325mg 10mg q.s.
156 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used. BP IP IP 50mg 325mg 10mg q.s.
157 Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Serratiopeptidase ( Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved Colour Used. BP IP IP 50mg 325mg 15mg q.s.
158 Diclofenac Potassium & Metaxalone Tablets Each uncoated Tablet contains: Diclofenac Potassium Metaxalon Excipients Approved colour used. Remarks-New permission add on 14/02/2025 Sr.NO 924. BP 50mg 400mg q.s.
159 Diclofenac Potassium & Metaxalone Tablets Each uncoated tablet contains:- Diclofenac Potassium Metaxalone Excipients Approved colour used . IP USP 50mg 400mg q.s.
160 Diclofenac Potassium & Paracetamol Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients Approved colour used BP IP 50mg 325mg q.s.
161 Diclofenac Potassium & Paracetamol Tablets Each Uncoated Tablet Contains: Diclofenac Potassium Paracetamol Excipients BP IP 50mg 325mg q.s.
162 Diclofenac Potassium & Serratiopeptidase Tablets Each film coated Tablet contains: Diclofenac Potassium Serratiopeptidase (Eq. toenzyme activityof 30000units of enteric coated granules) Excipients Approved colour used. BP IP 50mg 15mg q.s.
163 Diclofenac Potassium & Serratiopeptidase Tablets Each film coated tablet contains : Diclofenac Potassium Serratiopeptidase (as enteric coated 20,000 unit of activated enzymatic activity of Serratiopeptidase ) Excipients Approved colour used. BP IP 50mg 10mg q.s.
164 Diclofenac Potassium & Thiocolchicoside Tablets Each enteric coated tablet contains: Diclofenac Potassium Thiocolchiside Excipients Approved colour used. IP IP 50mg 4mg q.s.
165 Diclofenac Potassium Sustained Release Tablets Each film coated sustainedrelease tablet contains: Diclofenac Potassium Excipients Approved colour used BP 100 mg q.s.
166 Diclofenac Potassium Tablets IP Each Filmcoated Tablet contains: Diclofenac Potassium Excipients Approved colour used IP 25mg q.s.
167 Diclofenac Potassium, Paracetamol & Trypsin Chymotrypsin Tablets Each enteric coated tablet contains: Diclofenac Potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity. Excipients Approved colour used. BP IP BP 50mg 325mg 50000AU q.s.
168 Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets Each film coated Tablet Contains: Diclofenac Potassium Paracetamol Chlorzoxazone Excipients Approved colour used BP IP IP 50mg 325mg 500mg q.s.
169 Diclofenac potassium, Paracetamol & Chymotrypsin Tablets (Discontinue AFTER GETTING APPROVAL AS PER S.No.892 which is in enteric coated formulation). Each Film coated Tablets Contains: Diclofenac potassium Paracetamol Trypsin Chymotrypsin 50000 Armour unit of enzymatic activity (Supplied by a purified concentrate which has specific Trypsin and chymotrypsin activity in ratio of Approximate six to one) Excipients Approved colour used BP IP 50 mg 325 mg 50000 AU q.s.
170 Diclofenac Sodium , Paracetamol & Chlorzoxazone Tablets Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Chlorzoxazone Excipients Colour:- Approved colour used IP IP USP 325 mg 50 mg 250mg q.s.
171 Diclofenac Sodium & Paracetamol Tablets Each film coated tablets contains: Diclofenac Sodium (as Enteric coated) Paracetamol Excipients Approved colour used IP IP 50mg 325mg
172 Diclofenac Sodium & Paracetamol Tablets IP Each Uncoated Bilayered tablet contains : Diclofenac Sodium Paracetamol Excipients Approved colour used. IP IP 50mg 325mg q.s.
173 Diclofenac Sodium & Serratiopeptidase Tablets Each film coated Tablet Contains: Diclofenac Sodium Serratiopeptidase (Eq. to enzyme activityof 20000 units of enteric coated granules) Excipients Approved Colour Used. IP IP 50mg 10mg q.s.
174 Diclofenac Sodium SR Tablet IP Each film coated Sustained Release tablet Contains Diclofenac Sodium Excipients Colour :- Approved colour used IP 100mg q.s
175 Diclofenac Sodium Tablets IP Each Enteric Coated Tablet Contains: Diclofenac Sodium Excipients Approved Colour Used IP 50mg q.s
176 Diclofenac, Paracetamol and Serratiopeptidase Tablets Each film coated tablet contains:- Diclofenac Sodium Paracetamol Serratiopeptidase (Eq.to Enzyme activity30000 Units of enteric coated granules) Excipients Colour:- Approved colour used IP IP IP 50 mg 325 mg 15 mg q.s.
177 Dicyclomine Hydrochloride& Paracetamol Tablets Each uncoated Tablet contains: Dicyclomine Hydrochloride Paracetamol Excipients Approved colour used IP IP 20mg 500mg q.s.
178 Digoxin Tablets IP Each Uncoated Tablet Contains: Digoxin Excipients IP 0.25mg q.s.
179 Digoxin Tablets IP Each uncoated Tablet Contains: Digoxin Excipients Approved colour used IP 0.25mg q.s.
180 Disulfiram Tablets Each Uncoated Tablet Contains:- Disulfiram Excipients Colour :- Approved colour used IP 200mg q.s
181 Domperidone DispersibleTablets Each uncoated dispersible tablet contains: Domperidone Excipients Approved colour used IP 10mg q.s
182 Doxofylline ( Sustained Release) & Montelukast Tablets Each Filmcoated Bilayered Tablet Contains : Doxofylline (as Sustained Release) Montelukast Sodium Equ. To Montelukast Excipients Approved colour used IP IP 400mg 10mg q.s.
183 Doxofylline & Ambroxol Hydrochloride Tablets Each Film coated Tablet Contains : Doxofylline Ambroxol Hydrochloride Excipients Approved colour used IP IP 400mg 30mg q.s.
184 Doxofylline Modified Release Tablets Each uncoated Modified Release Tablet contains : Doxofylline Excipients IP 650mg q.s.
185 Doxofylline Tablets IP Each film Coated Tablet Contains :- Doxofylline Excipients Colour :- Approved colour used IP 400mg q.s.
186 Doxofylline Tablets IP Each uncoated Tablet Contains :- Doxofylline Excipients IP 400mg q.s.
187 Doxofylline(SR) & Montelukast Sodium Tablets Each uncoated tablet contains: Doxofylline (As sustainedrelease) Montelukast Sodium Eq. to Montelukast IP IP 400 mg10mg q.s.
188 Doxycycline & Lactic Acid Bacillus Tablets Each Film coated Tablet Contains : Doxycycline Hyclate Equ. To DoxycyclineLactic Acid Bacillus Excipients Approved colour used IP 100mg 5 Billion Spores q.s.
189 Doxycycline Hyclate Tablets Each film coated Tablet Contains: Doxycycline Hyclate Equ. To Doxycycline Excipients Approved colour used. IP 100mg q.s.
190 Doxylamine Succinate & Pyridoxine HCl Tablets Each enteric coated tablet contains : Doxylamine Succinate Pyridoxine Hydrochloride Excipients Approved colour used USP IP 10mg 10mg q.s
191 Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used BP IP IP 10 mg 10 mg 2.5 mg q.s.
192 Doxylamine succinate, Pyridoxine hydrochloride & Folicacid Tablets Each enteric coated tablets contains: Doxylamine succinate Pyridoxinehydrochloride Folic acid Excipients Approved colour used USP IP IP 20 mg 20 mg 5 mg q.s.
193 Dried Aluminium Hydroxide, Magnesium Aluminium Silicate Hydrate, Magnesium Hydroxide & Simethicone Chewable Tablets Each uncoated Chewable Tablet Contains: Dried Aluminium Hydroxide Magnesium Aluminium Silicate Hydrate Magnesium Hydroxide Simethicone Excipients Colour: Erythrosine & Ponceau 4R IP IP IP 300mg 50mg 25mg 25mg q.s
194 Drotaverine hydrochloride & Mefenamic Acid Tablets Each film coated tablets: Drotaverine hydrochloride Mefenamic Acid Excipients Approved colour used IP IP 80 mg 250 mg q.s.
195 Drotaverine Hydrochloride Tablet IP Each film coated tablet Contains :- Drotaverine Hydrochloride Excipients Colour :- Approved colour used IP 40mg q.s.
196 Drotaverine Hydrochloride Tablets IP Each uncoated Tablet contains Drotaverine Hydrochloride Excipients Approved Coloured used IP 80mg q.s
197 Drotaverine Hydrochloride Tablets IP Each Film coated Tablet contains Drotaverine Hydrochloride Excipients Colour : Approved Coloured used IP 80mg q.s
198 Duloxetine Gastro- resistant Tablets IP Each enteric coated Tablet contains : Duloxetine Hydrochloride Equ. To Duloxetine Excipients Approved Colour used. IP 20mg q.s.
199 EbastineTablet IP Each film coated tablet contains: Ebastine Excipients Approved colour used IP 10 mg q.s
200 EbastineTablet IP Each film coated tablet contains: Ebastine Excipients Approved colour used IP 20 mg q.s
201 Empagliflozin & Linagliptin Tablets Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . 10mg 5mg q.s.
202 Empagliflozin & Linagliptin Tablets Each film coated tablet contains:- Empagliflozin Linagliptin Excipients Approved colour used . 25mg 5mg q.s.
203 Erythromycin StearateTablet IP Each film coated Tablet Contains: Erythromycin Stearate Equ. toErythromycin Excipients Colour:- Approved colour used IP 250mg
204 Escitalopram Oxalate & Clonazepam Tablet IP Each film coated Tablet Contains:- Escitalopram Oxalate Equivalent toEscitalopram Clonazepam Excipient Approved colour used IP IP 10 mg 0.5 mg q.s.
205 Escitalopram OxalateTablet Each film coated Tablet Contains: Escitalopram oxalate Equ. toEscitalopram Excipients Colour : Approved Coloured Used IP 10mg q.s
206 Esomeprazole Gastro?esistant Tablet IP Each Enteric coated Tablet contains :- Esomeprazole magnesium Trihydrate Equ. to Esomeprazole Excipients Colour : Approved Coloured Used IP 40mg q.s.
207 Etizolam Tablets Each film coated tablet contains: Etizolam Excipients Approved colour used 0.25 mg q.s
208 Etizolam Tablets Each film coated tablet contains: Etizolam Excipients Approved colour used 0.5 mg q.s
209 Etodolac Extended Release Tablets USP Each Film Coated Extended Release Tablet contains : Etodolac Excipients Approved colour used IP 600mg q.s.
210 Etodolac Tablets IP Each Film Coated Tablet contains: Etodolac Excipients Approved colour used IP 400mg q.s.
211 Etodolac Tablets IP Each Film Coated Tablet contains: Etodolac Excipients Approved colour used IP 300mg q.s.
212 Etophylline & Theophylline Prolonged Release Tablet IP Each Film coated prolonged release Tablet contains Etophylline Theophylline Anhydrous Equ. To Theophyllinehydrate Excipients Colour : Approved Coloured Used IP IP 115mg 35mg q.s
213 Etoricoxib & Paracetamol Tablets Each film coated tablet Contains:- Etoricoxib Paracetamol Excipients Colour :- Approved colour used IP IP 60mg 325mg q.s
214 Etoricoxib & Thiocolchicoside Tablets Each film coated tablet Contains:- Etoricoxib Thiocolchicoside Excipients Colour :- Approved colour used IP IP 60mg 4mg q.s
215 Etoricoxib and Pregabalin (Prolonged Release) Tablets Each uncoated bilayered tablet contains: Etoricoxib Pregabalin (As prolonged release) Excipients Approved colour used. IP IP 60 mg 75 mg q.s.
216 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:- Approved Colour Used IP 90 mg q.s.
217 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:- Approved Colour Used IP 60 mg q.s.
218 Etoricoxib tablets IP Each film coated tablet contains:- Etoricoxib Excipients Colour:- Approved Colour Used IP 120 mg q.s.
219 Febuxostat Tablet Each film coated tablet contains: Febuxostat Excipients Approved colour used 120 mg q.s
220 Febuxostat Tablets Each film coated tablet contains:- Febuxostat Excipients Colour:- Approved colour used 40 mg q.s.
221 Febuxostat Tablets Each film coated tablet contains:- Febuxostat Excipients Colour:- Approved colour used 80 mg q.s.
222 Ferrous Ascorbate , Folic Acid & Zinc Tablet Each film coated Tablet Contains: Ferrous Ascorbate Equ. toElemental Iron Folic Acid Zinc Sulphate Monohydrate Equ. to Elemental Zinc Excipients Approved Colour Used. IP IP 100mg 1.5mg 22.5mg q.s.
223 Ferrous Ascorbate , Folic Acid, Methylcobalamin & Zinc Sulphate Monohydrate Tablet Each Film Coated Tablet Contains: Ferrous Ascorbate Equ. ToElemental IronFolic Acid Methylcobalamin Zinc Sulphate Monohydrate Equ. To Elemental Zinc Excipients Approved Colour Used IP IP IP IP 100mg 1.1mg 1.5mg 22.5mg q.s.
224 Ferrous Ascorbate (SR) and L-Methylfolate Tablets Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron (In sustained release form) Calcium L-5 Methyltetrahydrofolate Eq. to L-Methylfolate Excipients Approved colour used. Appropriate overages of L-Methylfolate added to compensate loss on storage. I.P. U.S.P q.s. 100mg 0.5mg
225 Ferrous Ascorbate & Folic Acid Tablets Each film coated tablet contains:- Ferrous Ascorbate Eq.toElemental Iron Folic Acid Excipients Colour:- Approved colour used IP 100 mg 1.5 mg q.s.
226 Ferrous Ascorbate, Folic Acid & Methylcobalamin Tablets Each film coated tablets contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Methylcobalamin Excipients Approved Colour used. Appropriate overages of vitamins added to compensate the loss on storage. I.P. I.P. 100mg 1.5mg 1500 mcg qs
227 Ferrous Ascorbate, Folic acid, Cyanocobalamin & Zinc Tablet Each film coatedtablet contain: Ferrous Ascorbate Equ. toElmental Iron Folic acid Zinc Sulphate Monohydrate Equ. To Elmental Zinc Cyanocobalamin Excipients Approved colour used IP IP IP 100 mg 1.5mg 22.5mg 15mcg q.s
228 Fexofenadine & Montelukast ChewableTablets Each Uncoated Chewable Tablet Contains : Fexofenadine Hydrochloride Montelukast Sodium Equ. To Montelukast Excipients IP IP 120mg 10mg q.s.
229 Fexofenadine & Montelukast Tablet Each uncoated Tablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Montelukast Sodium Equ. to Montelukast Excipients Colour : Approved Colour Used IP IP 120mg 10mg q.s.
230 Fexofenadine Hydrochloride & Montelukast Tablets Each film coated tablet contains: Fexofenadine Hydrochloride Montelukast sodium Equ. To Montelukast Excipients Approved colour used. IP IP 120mg 10mg q.s.
231 Fexofenadine Hydrochloride Tablet IP Each uncoated Tablet contains Fexofenadine Hydrochloride Equ. to Fexofenadine Excipients Colour : Approved Colour Used IP 120mg q.s.
232 Fexofenadine Hydrochloride Tablets IP Each Film coated Tablets Contains: Fexofenadine Hydrochloride Excipients Approved colour used IP 180 mg q.s.
233 Fexofenadine Hydrochloride Tablets IP Each film coated tablet contains: Fexofenadine Hydrochloride Excipients Approved colour used. IP 120mg q.s
234 Flavoxate Tablet IP Each film coated tablet contains: Flavoxate Excipients Approved colour used IP 200 mg q.s
235 Fluconazole Tablet IP Each Uncoated Tablet Contains : - Fluconazole Excipients Colour : - Approved Colour used IP 150mg q.s.
236 Fluconazole Tablets IP Each uncoated tablet Contains: Fluconazole Excipients Approved colour used IP 400mg q.s.
237 FluconazoleTablets IP Each uncoated tablets contains: Fluconazole Excipients Approved colour used IP 200 mg q.s.
238 Flunarizine Tablets Each Uncoated Tablet Contains: Flunarizine (as Flunarizine Dihydrochloride) Excipients Approved colour used BP 5mg q.s.
239 Flunarizine Tablets IP Each uncoated Tablet contains Flunarizine Hydrochloride Excipients Approved Coloured used BP 10mg q.s
240 Fluoxetine & Alprazolam Tablets Each uncoated tablet contains: Fluoxetine Hydrochloride Eq. to fluoxetine Alprazolam Excipients Approved colour used IP IP 20 mg 0.25 mg q.s
241 FluoxetineTablet IP Each film coated tablet Contains :- Fluoxetine Hydrochloride Equ. to Fluoxetine Excipients Colour :- Approved colour used IP 20mg q.s.
242 Flupentixol Dihydrochloride & Melitracen Hydrochloride Tablets Each film coated tablet contains : Flupentixol Dihydrochloride Equ. To Flupentixol Melitracen Hydrochloride Equ. To Melitracen Excipients Approved colour used. BP 0.5mg 10mg q.s
243 Folic Acid Tablets IP Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used IP 5mg q.s
244 Folic Acid Tablets IP Each uncoated Tablet Contains: Folic Acid Excipients Approved Colour used IP 10mg q.s
245 Frusemide Tablets IP Each uncoated tablet contains: Frusemide Excipients Approved colour used. IP 40mg q.s.
246 Furosemide Tablets IP Each Uncoated Tablet Contains: Furosemide Excipients IP 40mg q.s.
247 Gabapentin & Methylcobalamin Tablet Each film coated tablet contains; Gabapentin Methylcobalamine Excipients Approved colour used IP IP 300mg 500mcg q.s
248 Gabapentin & Methylcobalamin Tablets Each film coated Tablet Contains: Gabapentin Methylcobalamin Excipients Approved colour used. IP IP 100mg 500mcg q.s.
249 Gabapentin and Nortriptyline Tablets Each film coated Tablet contains: Gabapentin Nortriptyline Hydrochloride Equ. To Nortriptyline Excipients Approved colour used IP IP 300mg 10mg q.s
250 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 100 mg q.s
251 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 400 mg q.s
252 Gabapentin Tablet IP Each film coated tablet contains: Gabapentin Excipients Approved colour used IP 800 mg q.s
253 Gliclazide & Metformin Hydrochloride(SR) Tablets Each Uncoated Bilayered Tablet Contains: Gliclazide Metformin Hydrochloride (as Sustained Release) IP IP 80mg 500mg q.s.
254 Glimepiride & Metformin Hydrochloride (SR) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Releaseform) Excipients Approved colour used IP IP 3mg 500mg q.s.
255 Glimepiride & Metformin Hydrochloride (SR) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride (as Sustained Releaseform) Excipients Approved colour used IP IP 4mg 1000mg q.s.
256 Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets Each uncoated Bilayered Tablet contains: Glimepiride Metformin Hydrochloride ( as Sustained Release) Excipients Approved colour used. IP IP 3mg 1000mg q.s.
257 Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets IP Each uncoated Bilayered tablet contains: Glimepiride Metformin Hydrochloride (as sustained release) Excipients Approved colour used. IP IP 1mg 1000mg q.s.
258 Glimepiride, Metformin Hydrochloride (ER) & Voglibose Tablets Each uncoated Bilayered Tablet Contains : Glimepiride Metformin Hydrochloride (as Extended Release) Voglibose Excipients Approved colour used IP IP IP 1mg 500mg 0.3mg q.s.
259 GlimepirideTablet IP Each uncoated tablet contains: Glimepiride Excipients Approved colour used IP 1 mg q.s.
260 GlimepirideTablet IP Each uncoated tablet contains: Glimepiride Excipients Approved colour used IP 2 mg q.s.
261 Griseofulvin Tablets IP Each uncoated Tablet Contains: Griseofulvin Excipients Approved Colour Used IP 250mg q.s
262 Griseofulvin Tablets IP Each Uncoated Tablet Contains: Griseofulvin Excipients IP 500mg q.s.
263 Haloperidol Tablet IP Each Uncoated Tablet Contains: Haloperidol Excipients IP 5mg q.s.
264 Hydoxychloroquine Tablets IP Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients IP 200 mg q.s.
265 Hydoxychloroquine Tablets IP Each film coatedtablets contain: Hydroxychloroquine Sulphate Excipients IP 400 mg q.s.
266 Hydrochlorothiazid e tablet IP Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used IP 25mg q.s
267 Hydrochlorothiazid e tablet IP Each film coated tablet contains:- Hydrochlorothiazide Excipients Colour : Approved Colour Used IP 50mg q.s
268 Hydroxyzine Hydrochloride Tablet Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used IP 10mg q.s.
269 Hydroxyzine Hydrochloride Tablet Each uncoated tablet contains Hydroxyzine Hydrochloride eq. to Hydroxyzine Excipients Colour :- Approved Colour Used IP 25mg q.s.
270 Hydroxyzine Hydrochloride Tablets IP Each Film Coated Tablet Contains: Hydroxyzine Hydrochloride Excipients Approved colour used. IP 25mg q.s.
271 Hyoscine Butylbromide IP Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients Approved colour used. IP 10mg q.s.
272 Hyoscine Butylbromide Tablets IP Each Film coated Tablet Contains : Hyoscine Butylbromide Excipients Colour: Approved colour used. IP 10mg q.s.
273 Ibuprofen & Paracetamol Tablets Each uncoated Tablet Contains Ibuprofen Paracetamol Excipients Approved Colour Used IP IP 400mg 325mg q.s
274 Ibuprofen Tablets IP Each film coated Tablet contains: Ibuprofen Excipients Approved colour used IP 200mg
275 Ibuprofen Tablets IP Each film coated Tablet contains: Ibuprofen Excipients Approved colour used IP 400mg
276 Isosorbide Dinitrate Tablets IP Each Uncoated Tablet Contains: Isosorbide Dinitrate Excipients Approved colour used IP 5mg q.s.
277 Isoxsuprine Tablets (Sustained Release) Each uncoated Sustained Release Tablet Contains Isoxsuprine Hydrochloride Excipients Approved colour used IP 40mg q.s
278 Ivermactin Tablet IP Each uncoated tablet contains: Ivermactin Excipients Approved colour used IP 6 mg q.s
279 Ivermactin Tablet IP Each uncoated tablet contains: Ivermactin Excipients Approved colour used IP 12 mg q.s
280 Ivermectin & Albendazole Tablets Each uncoated tablet contains: Ivermactin Albendazole Excipients Approved colour used IP IP 12 mg 400mg q.s
281 Ketoconazole Tablet IP Each uncoated tablet contain: Ketoconazole Excipients Approved colour used IP 200 mg q.s
282 Ketrolac Tromethamine DispersibleTablets Each uncoated dispersible tablets contains: Ketrolac Tromethamine Excipients Approved colour used IP 10 mg q.s.
283 L- Carnitine , L- Tartrate, Folic Acid & Methylcobalamin Tablets Each film coated Tablet contains: L-Carnitine L-Tartrate Equ. To L-Carnitine Methylcobalamin Folic Acid Excipients Approved colour used IP IP 500mg 1500mcg 1.5mg q.s.
284 L-Carnitine L- Tartrate, Methylcobalamin and Folic Acid Tablets Each Film Coated Tablet Contains: L-Carnitine L-Tartrate Methylcobalamin Folic Acid Excipients Approved colour used. IP IP 500mg 1500mcg 1.5mg q.s.
285 L-Mehtylfolate, Methylcobalamin & Pyridoxal-5-Phosphate Tablets Each film coated tablet contains: Calcium L-5 Methyltetrahydrofolate Equivalent to L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used Appropriate overages of vitamins added to compensate the possible loss on storage. U.S.P. I.P. 5 mg 1500 mcg 0.5 mg q.s.
286 L-methylfolate Calcium, Methylcobalamin, Pyridoxal-5-Phosphate Tablets Each film coated tablet contains:- L-methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Approved colour used . IP 1mg 1500mcg 0.5mg q.s.
287 Labetalol Tablets IP Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used. IP 50mg q.s
288 Labetalol Tablets IP Each film coated Tablet Contains: Labetalol Hydrochloride Excipients Approved colour used. IP 100mg q.s
289 Lactulose Solution USP Each 15ml contain: Lactulose In flavoured Syrupybase Approved colour used USP 10 gm. Q.s.
290 Lansoprazole orally Disintegrating Tablets Each uncoated tablet contains: Lansoprazole (as enteric coated pellets) Excipients Approved colour used IP 15 mg q.s.
291 Lansoprazole Orally Disintegrating Tablets 30mg Each uncoated orallyDisintegrating tablet contains: Lansoprazole (As enteric coated pellets ) Excipients Approved colour used. IP 30mg q.s.
292 Leflunomide Tablet IP Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used IP 20mg q.s
293 Leflunomide Tablet IP Each film coated Tablet Contains: Leflunomide Excipients Colour : Approved Coloured Used IP 10mg q.s
294 Letrozole Tablets USP Each film coated Tablet contains: Letrozole Excipients Approved colour used. USP 2.5mg q.s.
295 Levetiracetam Tablet IP Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used IP 250mg q.s
296 Levetiracetam Tablet IP Each film Coated Tablet Contains :- Levetiracetam Excipients Colour :- Approved colour used IP 500mg q.s
297 Levocetirizine Dihydrochloride & Montelukast DispersibleTablets Each uncoated dispersible Tablet contains : Levocetirizine Dihydrochloride Montelukast sodium Equ. To Montelukast Excipients IP IP 2.5mg 4mg q.s
298 Levocetirizine Dihydrochloride Tablets IP Each Uncoated Tablet Contains:- Levocetirizine Dihydrochloride Excipients Colour :- Approved colour used IP 5mg q.s.
299 Levocetirizine Dihydrochloride Tablets IP Each film Coated Tablet Contains : Levocetirizine Dihydrochloride Excipients Approved colour used. IP 5mg q.s.
300 Levocetirizine Hydrochloride Tablets IP Each Film coated Tablet Contains : Levocetirizine Hydrochloride Excipients Approved colour Used. IP 10mg q.s.
301 Levodopa & Carbidopa Tablets IP Each Uncoated Tablet Contains: Carbidopa Equ. To Carbidopa AnhydrousLevodopa Excipients Approved colour used IP IP 25mg 250mg q.s.
302 Levofloxacin & OrnidazoleTablets Each film coated tablets contains: Levofloxacin hemihydrate Equivanent to Levofloxacin anhydrous Ornidazole Excipients Approved colour used IP IP 250 mg 500 mg q.s.
303 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:- Approved colour used IP 250 mg. q.s.
304 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:- Approved colour used IP 500 mg. q.s.
305 Levofloxacin Tablets IP Each film coated tablet contains:- Levofloxacin Hemihydrate Equivalent to Levofloxacin Excipients Colour:- Approved colour used IP 750 mg. q.s.
306 Levosulpiride Tablets Each Uncoated Tablet Contains: Levosulpiride Excipients 25mg q.s.
307 Levothyroxine sodium Tablets USP Each uncoated Tablet Contains: Levothyroxine Sodium Equ. To Anhydrous Levothyroxine SodiumExcipients USP 50mcg q.s.
308 Linezolid Tablet IP Each film coated tablet contains:- Linezolid Excipients Colour:- Approved colour used IP 600 mg q.s.
309 Lithium Carbonate Prolonged ?Release Tablets IP Each uncoated Prolonged-Release tablet contains: Lithium Carbonate Excipients Approved colour used. IP 450mg q.s.
310 Loperamide Hydrochloride Tablets IP Each uncoated tablet contains:- Loperamide Hydrochloride Excipients Colour : Approved Coloured Used IP 2 mg q.s.
311 Loratadine Tablet USP Each uncoated table contains:- Loratadine Excipients Approved colour used USP 10 mg q.s.
312 Lornoxicam & Paracetamol Tablets Each film coated Tablet Contains :- Lornoxicam Paracetamol Excipients Colour :- Approved colour used IP IP 4mg 325mg q.s.
313 Lornoxicam & Paracetamol Tablets Each film coated Tablet Contains :- Lornoxicam Paracetamol Excipients Colour :- Approved colour used IP IP 8mg 325mg q.s.
314 Losartan Potassium & Amlodipine Besilate Tablet IP Each film coated tablet contains: Losartan Potassium Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 50 mg 5 mg q.s.
315 Losartan Potassium & Hydrochlorothiazid e Tablet IP Each film coated tablet contains: Losartan Potassium Hydrochlorothiazide Excipients Approved colour used IP IP 50 mg 12.5 mg q.s.
316 Losartan Potassium Tablet IP Each film coated tablet contains: Losartan Potassium Excipients Approved colour used IP 50 mg
317 Losartan potassium Tablets IP Each film coated tablet contains: Losartan potassium Excipients Approved colour used. IP 25mg q.s.
318 Mecobalamin Tablets Each film coated Tablet contains: Mecobalamin Excipients Approved colour used. IP 1500mcg q.s.
319 Mecobalamin, Alpha Lipoic Acid, Benfotiamine, Folic acid,Chromium Picolinate,Inositol, Pyridoxine HCL, Vitamin D3, & Calcium Carbonate Tablets Each film coated tablet contains: Mecobalamin Alpha Lipoic Acid Benfotiamine Folic acid Chromium Picolinate Inositol, Pyridoxine HCL Vitamin D3 Calcium Carbonate Excipients Approved colour used. IP IP IP IP IP IP IP IP 1500 mcg 100 mg 150 mg 1.5 mg 200 mcg 100 mg 3 mg 1000 IU 500mg q.s.
320 Mefenamic Acid & Dicyclomine HCl Tablets Each uncoated Tablet contains: Mefenamic Acid Dicyclomine HCl Excipients IP IP 250mg 20mg q.s
321 Mefenamic Acid & Dicyclomine Tablets IP Each uncoated tablet contains:- Mefenamic Acid Dicyclomine Hydrochloride Excipients Colour:- Approved Colour used IP IP 250 mg 10 mg q.s.
322 Mefenamic Acid & Paracetamol Tablet Each uncoated tablet contain: Mefenamic Acid Paracetamol Excipients Approved colour used IP IP 500 mg 325 mg q.s.
323 Mefenamic Acid & Paracetamol Tablets Each uncoated tablet contains: Mefenamic Acid Paracetamol Excipients Approved Colour used IP IP 250mg 325mg q.s.
324 Memantine Hydrochloride & Donepezil Hydrochloride Tablets Each film coated tablet contains: Memantine Hydrochloride Donepezil Hydrochloride Excipients Approved colour used. IP IP 5mg 5mg q.s.
325 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used IP IP 500 mg 1 mg q.s.
326 Metformin Hydrochloride (Prolong Release) and Glimepiride Tablet IP Each uncoated bilayer tablet contains:- Metformin Hydrochloride (Prolonged Release) Glimepiride Excipients Colour:- Approved Colour Used IP IP 500 mg 2 mg q.s.
327 Metformin Hydrochloride (SR) & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used. IP IP 2mg 500mg q.s.
328 Metformin Hydrochloride (Sustained Release) , Gliclazide (Sustained Release) & Pioglitazone Tablets Each uncoated Bilayered Tablet Contains: Metformin Hydrochloride (as Sustained Release) Gliclazide (as Sustained Release) Pioglitazone Hydrochloride Equ. To Pioglitazone Excipients Approved colour used. IP IP IP 500mg 30mg 15mg q.s.
329 Metformin Hydrochloride (Sustained Release) & Glimepiride Tablets IP Each Uncoated Bilayered Tablet Contains: Glimepiride Metformin Hydrochloride (as Sustained Release) Excipients Approved colour used. IP IP 1mg 500mg q.s.
330 Metformin Hydrochloride & GliclazideTablets Each uncoated tablets contains: Metformin hydrochloride Gliclazide Excipients Approved colour used IP IP 500 mg 80 mg
331 Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP Each uncoated Bilayered tablet contains: Metformin Hydrochloride (as Prolonged Release) Glimepiride Excipients Approved colour used IP IP 1000mg 2mg q.s
332 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 500mg q.s.
333 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 850mg q.s.
334 Metformin Hydrochloride Sustained-Release Tablets Each uncoated Sustained Release Tablet Contains : Metformin Hydrochloride Excipients IP 1000mg q.s.
335 Metformin Hydrochloride Tablets IP Each uncoated sustainedrelease tablet contains: Metformin Hydrochloride Excipients Approved colour used IP 500 mg q.s.
336 Metformin hydrochloride,(ER) Pioglitazone and GlimepirideTablets Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride Eq.to Pioglitazone Glimepiride Excipients IP IP IP 500 mg 15 mg 2 mg q.s
337 Metformin hydrochloride,(ER) Pioglitazone and Glimipride Tablets Each uncoated Bilayered tablets contain: Metformin hydrochloride (as Extended release) Pioglitazone Hydrochloride. Eq.to Pioglitazone Glimepiride Excipients Approved colour used IP IP IP 500 mg 15 mg 1 mg q.s
338 Methotrexate Tablets IP Each uncoated tablet contains: Methotrexate Excipients Approved colour used. IP 2.5mg q.s.
339 Methylcobalamin Sublingual Tablets Each uncoated sublingual tablet contains : Methylcobalamin Excipients IP 1500mcg q.s.
340 Methylcobalamin Tablets Each film coated Tablet Contains: Methylcobalamin Excipients Approved colour used. 1500mcg q.s.
341 Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Thiamine Mononitrate & Folic Acid Tablets Each film coated tablet contains: Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used. IP USP IP IP IP 1500mcg 100mg 3mg 10mg 1.5mg q.s.
342 Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride,Thiamine Mononitrate & Folic Acid Tablets Each film coated tablet contains: Methylcobalamin Alpha Lipoic Acid Pyridoxine Hydrochloride Thiamine Mononitrate Folic Acid Excipients Approved colour used. IP USP IP IP IP 1500mcg 100mg 3mg 10mg 1.5mg q.s.
343 Methylcobalamin, Calcium Citrate, Calcitriol, Folic Acid & Pyridoxine Hydrochloride Tablets Each film coated Tablet Contains: Methylcobalamin Calcium Citrate Calcitriol Folic Acid Pyridoxine Hydrochloride Excipients Approved colour used IP USP IP IP IP 1500mcg 750mg 0.25mcg 1.5mg 3mg q.s.
344 Methylcobalamin, L-Methylfolate & Pyridoxine HCl Tablets Each film coated Tablet Contains : Methylcobalamin L-Methylfolate Pyridoxine HCl Excipients Approved Colour Used IP IP 1500mcg 1MG 0.5mg q.s
345 Methylcobalamin, L-Methylfolate, PyridoxalPhosphate, Vitamin D3 & Docosahexaenoic Acid (DHA) Tablets Each film coated tablet contains:Methylcobalamin L-Methylfolate Pyridoxal Phosphate Vitamin D3 Docosahexaenoic Acid (DHA) Excipients Approved colour used. Appropriate overages of vitamins added to compensate the loss on storage. I.P. I.P. I.P. I.P. 1500 mcg 1.0 mg 0.5 mg 1000 IU 100 mg q.s.
346 Methylcobalamine, Alpha Lipoic Acid Vitamin D3,Pyridoxine Hydrochloride ,Folic Acid Tablets Each film coated Tablet Contains: Methylcobalamine Alpha LipoicAcid Vitamin D3 Pyridoxine Hydrochloride Folic Acid Excipients Approved Colour Used. IP USP IP IP IP 1500mcg 100mg 1000IU 3mg 1.5mg q.s.
347 Methylprednisolone Tablets Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 8 mg q.s.
348 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 4 mg q.s.
349 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 2 mg q.s.
350 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 16 mg q.s.
351 Methylprednisolone Tablets IP Each uncoated tablet contains:- Methylprednisolone Excipients Colour :- Approved Colour Used IP 16 mg q.s.
352 Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used IP IP 47.5 mg 50 mg 12.5 mg q.s.
353 Metoprolol Succinate (ER) & Hydrochlorothiazid e Tablets Each uncoated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Hydrochlorothiazide Excipients Approved colour used IP IP 23.75 mg 25 mg 12.5 mg q.s.
354 Metoprolol Succinate (ER) Tablets IP Each film coated tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release Excipients"Approved colour used IP 47.5 mg 50 mg q.s.
355 Metoprolol Succinate Prolonged release Tablets IP Each film coated Prolonged release Tablet Contains Metoprolol succinate Equ. to Metoprolol Tartrate Excipients Colour :- Approved colour used IP 23.75mg 25mg q.s.
356 Metoprolol Succinate(ER) & Amlodipine Besilate Tablets Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 47.5 mg 50 mg 5 mg q.s.
357 Metoprolol Succinate(ER) & Amlodipine Besilate Tablets Each film coated Bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 23.75 mg 25 mg 5 mg q.s.
358 Metoprolol SuccinateExtended release Tablets IP Each film coated Extended release Tablet Contains Metoprolol succinate Equ. To Metoprolol TartrateExcipients Colour :- Approved colour used IP 11.875mg 12.5mg q.s.
359 Metronidazole Oral solution Each 5ml contains : Metronidazole Benzoate Equ. To Metronidazole In a flavoured Syrupy Base. Colour : Approved Coloured Used IP 250mg q.s
360 Metronidazole Tablet IP Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used IP 200mg q.s
361 Metronidazole Tablet IP Each film coated Tablet Contains: Metronidazole Excipients Colour : Approved Coloured Used IP 400mg q.s
362 Minocycline Hydrochloride Tablet Each film coated Tablet Contains Minocycline Hydrochloride Equ. To Minocycline Excipients Colour : Approved Coloured Used USP 100mg q.s
363 Minoxidil Tablets IP Each Uncoated Tablet Contains: Minoxidil Excipients IP 5mg q.s.
364 Minoxidil Tablets IP Each uncoated tablet Contains: Minoxidil Excipients Approved colour used IP 2.5mg q.s.
365 Minoxidil Topical solution USP Each ml contains: Minoxidil Excipients Approved colour used IP 20mg q.s
366 Mometasone Furoate & Terbinafine Hydrochloride Cream Composition:- Mometasone Furoate Terbinafine Hydrochloride Cream Base IP IP 0.1% w/w 1% w/w q.s.
367 Montelukast & Doxophylline (SR) Tablets Each uncoated tablet contains:- Montelukast Sodium Equivalent to Montelukast Doxophylline (As Sustained Release) Excipients Colour:- Approved colour used IP IP 10 mg 400 mg q.s
368 Montelukast & Levocetirizine HCL Dispersible Tablets Each uncoated dispersible tablet contains: Montelukast sodium Eq.to Montelukast Levocetirizine HCL Excipients Approved colour used. IP IP 4 mg 2.5 mg
369 Montelukast & Levocetirizine HCl Tablets Each uncoated Bilayered Tablet Contains : Montelukast Sodium Equ. To Montelukast Levocetirizine Hydrochloride Excipients Approved colour used. IP IP 10mg 5mg q.s.
370 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each Uncoated Tablet Contains:- Montelukast Sodium eq. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used IP IP 4mg 2.5mg q.s.
371 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each film coated Tablet Contains:- Montelukast Sodium eq. to Montelukast LevocetirizineDihydrochloride Excipients Approved colour used IP IP 10 mg 5mg q.s.
372 Montelukast sodium & Bambuterol Hydrochloride Tablets Each film coated Tablet contains: Montelukast sodium Equ. To Montelukast Bambuterol Hydrochloride Excipients Approved colour used IP BP 10mg 10mg q.s.
373 Montelukast Sodium & Desloratadine Tablet Each film coated Tablet Contains:- Montelukast Sodium Equivalent to Montelukast Desloratadine Excipients Approved colour used IP BP 10 mg 5 mg q.s
374 Montelukast Sodium & Levocetirizine Dihydrochloride DispersibleTablets Each Uncoated Dispersible Tablet Contains : Montelukast Sodium Equ. To Montelukast LevocetirizineDihydrochloride Excipients Colour : Approved Coloured used IP IP 5mg 2.5mg q.s.
375 Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP Each uncoated Tablet contains: Montelukast sodium Equ. To Montelukast LevocetirizineDihydrochloride Excipients Approved colour used. IP IP 10mg 5mg q.s.
376 Montelukast Sodium Chewable Tablets Each Uncoated Chewable Tablet Contains : Montelukast sodium Equ. To Montelukast Excipients IP 4mg q.s.
377 Montelukast Sodium, Fexofenadine Hydrochloride and Sustained Release Acebrophylline Tablets Each film coated Tablet contains: Montelukast sodium Equ. To Montelukast Fexofenadine Hydrochloride Acebrophylline (As sustainedrelease form) Excipients Approved colour used IP IP 10mg 120mg 200mg q.s
378 Montelukast sodium, Levoceterizine dihydrochloride & Ambroxol hydrochloride Tablets Each film coated tablets contains: Montelukast sodium Equivalent to Montelukast Levoceterizine dihydrochloride Ambroxol hydrochloride (As sustainedrelease) Excipients Approved colour used IP IP IP 10 mg 5 mg 75 mg q.s.
379 Montelukast SodiumTablets IP Each Film coated Tablet Contains : Montelukast Sodium Equ. To Montelukast Excipients Approved colour used IP 10mg q.s.
380 Moxifloxacin Hydrochloride Tablets Each Film coated Tablet Contains : Moxifloxacin Hydrochloride Equ. To Moxifloxacin Excipients Approved colour used. IP 400mg q.s.
381 Moxonidine Tablets Each film coated tablet contains: Moxonidine Excipients Approved colour used BP 0.2mg q.s.
382 Moxonidine Tablets Each film coated tablet contains: Moxonidine Excipients Approved colour used BP 0.3mg q.s.
383 Naproxen & Domperidone Tablets Each film coated tablet contains: Naproxen Domperidone Excipients Approved colour used IP IP 500mg 10mg q.s
384 Naproxen & Domperidone Tablets Each Film coatedtablet contains: Naproxen Domperidone Excipients Approved colour used. IP IP 250 mg 10 mg q.s
385 Naproxen Sodium & Domperidone Tablet Each uncoated tablet contain: Naproxen Sodium Domperidone Excipients Approved colour used IP IP 250 mg 10 mg q.s
386 Naproxen Sustained Release Tablets IP Each uncoated sustained release tablet contains: Naproxen Excipients Approved colour used IP 750mg q.s.
387 Naproxen Tablet IP Each uncoated tablet contain: Naproxen Excipients Approved colour used IP 250 mg q.s
388 Naproxen Tablet IP Each uncoated tablet contain: Naproxen Excipients Approved colour used IP 500 mg q.s
389 Nebivolol & Hydrochlorothiazid e Tablets Each uncoated Tablets Contains: Nebivolol Hydrochloride Equ. To Nebivolol Hydrochlorothiazide Excipients Approved colour used. IP IP 5mg 12.5mg q.s.
390 Nebivolol Hydrochloride Tablets IP Each uncoated tablet contains: Nebivolol Hydrochloride Eq. to Nebivolol Excipients Approved colour used. IP 5mg q.s.
391 Nicorandil Tablets IP Each uncoated Tablets Contains: Nicorandil Excipients IP 5mg
392 Nicorandil Tablets IP Each uncoated Tablets Contains: Nicorandil Excipients IP 10mg
393 Nifedipine Prolonged Release Tablets BP Each Prolonged Release film coated tablet contains: Nifedipine Excipients Approved colour used. BP 30mg q.s.
394 Nimesulide & Paracetamol Tablets Each uncoated tablet contains: Nimesulide Paracetamol Excipients BP IP 100 mg 325 mg q.s.
395 Nimesulide & Paracetamol Tablets Each uncoated Bilayered Tablet contains: Nimesulide Paracetamol Excipients Approved colour used. BP IP 100mg 325mg q.s.
396 Nimesulide Mouth Dissolving Tablets Each uncoated Mouth dissolving Tablet contains : Nimesulide Excipients Approved colour used. BP 100mg q.s.
397 Nimesulide Tablets Each uncoated tablet contains:- Nimesulide Excipients Colour:- Approved colour used BP 100 mg q.s.
398 Nimesulide, Paracetamol & Chlorzoxazone Tablets Each film coated tablet contains: Nimesulide Paracetamol Chlorzoxazone Excipients Approved colour used BP IP USP 100mg 325mg 250mg q.s
399 Nimesulide, Paracetamol, Phenylephrine HCl & Caffeine Tablets Each uncoated Tablet Contains: Nimesulide Paracetamol Phenylephrine Hydrochloride Caffeine (anhydrous) Excipients BP IP IP IP 100mg 325mg 10mg 25mg q.s.
400 Nimesulide, Paracetamol, Serratiopeptidase Tablets Each film coated tablet contains : Nimesulide Paracetamol Serratiopeptidase ((Eq. to enzyme activityof 30000 units of enteric coated granules) Excipients Approved colour used. BP IP IP 100mg 325mg 15mg
401 Nimesulide, Phenylephrine HCL, Cetirizine Dihydrochloride & Caffeine Tablets Each uncoated tablet contains:- Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine (anhydrous) Excipients Colour:-Approved colour used BP IP IP IP 100 mg 10 mg 5 mg 30 mg q.s.
402 Nimesulide, Phenylephrine HCl& Levocetirizine HCl Tablets Each uncoated tablet contains: Nimesulide Phenylephrine HCl Levocetirizine HCl Excipients Approved Colour used BP IP IP 100mg 5mg 5mg q.s.
403 Nimesulide, Phenylephrine Hydrochloride, Cetirizine Dihydrochloride & Caffeine Tablets Each film Coated Tablet Contains : Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride Caffeine ( Anhydrous) Excipients Approved colour Used. BP IP IP IP 100mg 10mg 5mg 30mg q.s.
404 Nimodipine Tablets Each Film coated Tablet Contains : Nimodipine Excipients Approved colour used. IP 30mg q.s.
405 Nitrofurantoin SR Tablet Each Film Coated Sustained Release Tablet Contains Nitrofurantoin Excipients Colour :- Approved colour used BP 100mg q.s.
406 Nitroglycerine Controlled Release Tablet Each uncoated Tablet contains: Diluted Nitroglycerine Equ. To Nitroglycerin (as Controlled Release) Excipients Approved colour used IP 2.6mg q.s.
407 Norfloxacin & TinidazoleTablets Each film coated tablet contains:- Norfloxacin Tinidazole Excipients Colour:- Approved colour used IP IP 400 mg 600 mg q.s.
408 Norfloxacin Tablets IP Each film coated Tablet Contains: Norfloxacin Excipients Approved Colour Used IP 400mg q.s
409 Nortriptyline & Gabapentin Tablets Each Film coated Tablet Contains:- Nortriptyline Hydrochloride Equivalent to Nortriptyline Gabapentin Excipients Approved colour used IP IP 10 mg 400 mg q.s.
410 Nortriptyline & PregabalineTablets Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabaline Excipients Approved colour used IP IP 10 mg 75 mg q.s.
411 Nortriptyline, Pregabalin (SR) & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
412 Nortriptyline, Pregabalin & Mecobalamin Tablets Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Mecobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
413 Nortriptyline, Pregabalin & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
414 Ofloxacin & Lactic Acid Bacillus Tablets Each Film coated Tablet Contains : Ofloxacin Lactic Acid Bacillus Excipients Approved colour used. IP 200mg 60 Million Spores q.s.
415 Ofloxacin & Ornidazole Tablet IP Each Film Coated Tablet Contains: Ofloxacin Ornidazole Excipients Approved colour used IP IP q.s. 200 mg 500 mg
416 Ofloxacin & TinidazoleTablets Each film coated tablet contains: Ofloxacin Tinidazole Excipients Approved colour used. IP IP 200mg 600mg q.s.
417 Ofloxacin Tablet IP Each film coated tablet contains:- Ofloxacin Excipients Approved colour used IP 400 mg q.s.
418 Ofloxacin Tablets IP Each Film Coated Tablet Contains: Paracetamol Tramadol Hydrochloride Excipients Approved Colour Used IP IP 325mg 37.5mg q.s.
419 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 5mg q.s.
420 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 2.5mg q.s.
421 OlanzapineTablet IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 7.5 mg q.s.
422 OlanzapineTablets IP Each film coated tablet contains: Olanzapine Excipients Approved colour used IP 10 mg q.s.
423 Olmesartan & AmlodipineTablets Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate Eq. to Amlodipine Excipients Approved colour used IP IP 20 mg 5 mg q.s
424 Olmesartan & Chlorthalidone Tablets Each film coated tablet contains: Olmesartan Medoxomil Chlorthalidone Excipients Approved colour used IP IP 20 mg 12.5 mg q.s
425 Olmesartan & Hydrochlorothiazid e Tablets Each film coated tablet contains: Olmesartan Medoxomil Hydrochlorothiazide Excipients Approved colour used IP IP 20 mg 12.5 mg q.s
426 Olmesartan & Metoprolol SuccinateTablets Each film coated Bilayered tablet contains: Olmesartan Medoxomil Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used IP IP 20 mg 47.5 mg 50 mg q.s
427 Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazid e Tablets Each film coated Tablet Contains: Olmesartan Medoxomil Amlodipine Besylate Equ. To Amlodipine Hydrochlorothiazide Excipients Approved Colour used. IP IP IP 40mg 5mg 12.5mg q.s.
428 Olmesartan, Amlodipine & Hydrochlorothiazid e Tablets Each film coated tablet contains: Olmesartan Medoxomil Amlodipine Besilate Eq. to Amlodipine Hydrochlorothiazide Excipients Approved colour used IP IP IP 20 mg 5 mg 12.5 mg q.s
429 Olmesarton Medoxomil & Hydrochlorthiazide Tablet Each film coated tablet contains: Olmesarton Medoxomil Hydrochlorthiazide Excipients Approved colour used IP IP 40 mg 12.5 mg q.s.
430 Olmesarton Medoxomil Tablet IP Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used IP 20 mg q.s.
431 Olmesarton Medoxomil Tablet IP Each film coated tablet contains: Olmesarton Medoxomil Excipients Approved colour used IP 40 mg q.s.
432 Ondansetron Oral Solution IP Each 5 ml contains: Ondansetron Hydrochloride Equ. To Ondansetron Flavoured Syrupy Base IP 4mg q.s.
433 Ondansetron Orally Disintegrating TabletsTablet IP Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used. IP 4mg
434 Ondansetron Orally Disintegrating TabletsTablet IP Each Uncoated OrallyDisintegrating Tablets Contains Ondansetron hydrochloride Equ. toOndansetron Excipients Approved colour used. IP 8mg
435 Ornidazole , Diloxanide & Simethicone Tablets Each film coated tablet contains: Ornidazole Diloxanide furoate Simethicone Excipients Approved colour used. IP IP IP 250mg 375mg 25mg q.s.
436 Ornidazole Tablets Each Film coated Tablet Contains : Ornidazole Excipients Approved colour used. IP 500mg q.s.
437 Pancreatin, Simethicone & Activated Charcoal Tablets Each film coated Tablet Contains: Pancreatin Simethicone Activated Charcoal Excipients Approved colour used IP IP IP 175mg 50mg 50mg q.s.
438 Pantoprazole Gastro-resistant and Domperidone Prolonged ?elease Capsules IP Each hard gelatin capsule contains:- Pantoprazole Sodium Sesquihydrate Equivalent to Pantoprazole (As Enteric Coated Pellets) Domperidone "(As Prolonged Release Pellets) Excipients Approved colour used in emptycapsule shells." IP IP 40 mg 30 mg
439 Pantoprazole Gastro-Resistant Tablets IP Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Excipients Colour:- Approved colour used IP 40 mg q.s.
440 Pantoprazole Sodium & Domperidone Tablets Each enteric coated tablet contains:- Pantoprazole Sodium Eq. to Pantoprazole Domperidone Excipients Colour:- Approved colour used IP IP 40 mg 10 mg q.s.
441 Pantoprazole Tablets IP Each enteric coated Tablet contains : Pantoprazole sodium sesquihydrate Equ. To Pantoprazole Excipients Approved colour used. IP 20mg q.s.
442 Paracetamol (DT) Tablets BP Each uncoated dispersible tablet contains: Paracetamol Excipients Approved colour used. IP 650 mg q.s.
443 Paracetamol & Diclofenac Tablets IP Each uncoated tablet contains:- Paracetamol Diclofenac Sodium Excipients Colour:- Approved colour used IP IP 325 mg 50 mg q.s.
444 Paracetamol & Dicyclomine Hydrochloride Tablets Each uncoated Tablet contains: Paracetamol Dicyclomine Hydrochloride Excipients IP IP 325mg 20mg q.s.
445 Paracetamol & Domperidone Tablets Each uncoatedtablet contains : Paracetamol Domperidone Excipients Approved colour used. IP IP 325mg 10mg q.s.
446 Paracetamol and CaffeineTablets IP Each uncoated Tablet contains: Paracetamol Caffeine Excipients IP IP 650mg 50mg q.s.
447 Paracetamol and CaffeineTablets IP Each Film Coated Tablet contains: Paracetamol Caffeine Excipients Approved Colour used. IP IP 650mg 50mg q.s.
448 Paracetamol Bilayered Sustained Release Tablets Each uncoated Bilayered Sustained Release Tablet contains : Paracetamol (As Immediate Release) Paracetamol (As Sustained Release) Excipients Approved Colour used. IP IP 300mg 700mg q.s.
449 Paracetamol Tablets IP Each uncoated tablet contains:- Paracetamol Excipients Colour:- Approved colour used IP 650 mg q.s.
450 Paracetamol Tablets IP Each uncoated tablet contains:- Paracetamol Excipients Approved colour used IP 500 mg q.s.
451 Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets Each uncoated tablet contains: Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Excipients Approved colour used. IP IP IP 500mg 10mg 2mg q.s.
452 Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension Each 5ml Contains:- Paracetamol Phenylephrine HCL Chlorpheniramine Maleate Sodium Citrate Menthol In flavoured Syrupybase Approved colour used IP IP IP IP IP 250 mg 5 mg 0.5 mg 60 mg 1 mg q.s.
453 Paracetamol, Phenylephrine HCL,Caffeine , & Chlorpheniramine Maleate Tablets Each uncoated tablet contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Chlorpheniramine Maleate Excipients Approved colour used IP IP IP IP 500 mg 12.5 mg 30mg 2 mg q.s
454 Paracetamol, Phenylephrine Hydrochloride , Guaiphenesin, Cetirizine Hydrochloride & Ambroxol Hydrochloride Tablets Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Guaiphenesin Cetirizine Hydrochloride Ambroxol Hydrochloride Excipients Approved colour used. IP IP IP IP IP 325mg 5mg 50mg 5mg 15mg q.s.
455 Paracetamol, Phenylephrine Hydrochloride, Cetirizine Hydrochloride , Dextromethorphan Hydrobromide & Caffeine Tablets Each uncoatedtablet contains : Paracetamol Phenylephrine Hydrochloride Cetirizine Hydrochloride Dextromethorphan Hydrobromide Caffeine (Anhydrous) Excipients Approved colour used. IP IP IP IP IP 500mg 10mg 5mg 10mg 30mg q.s.
456 Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate &Caffeine Tablets Each uncoated Tablet contains: Paracetamol Phenylephrine Hydrochloride Chlorpheniramine Maleate Caffeine (Anhydrous) Excipients Approved Colour Used. IP IP IP IP 325mg 5mg 2mg 15mg q.s.
457 Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride & Caffeine (Anhydrous) Tablets Each uncoated tablet contains:- Paracetamol Phenylephrine Hydrochloride Diphenhydramine Hydrochloride Caffeine (Anhydrous) Excipients Colour:- Approved colour used IP IP IP IP 500 mg 5 mg 25 mg 30 mg q.s.
458 Paracetamol, Phenylpherine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets Each uncoated tablet contains: Paracetamol Phenylpherine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients Approved colour used. IP IP IP IP 325mg 5mg 30mg 25mg q.s.
459 Paroxetine Hydrochloride Tablet Each film coated Tablet Contains : Paroxetinehydrochloride Hemihydrate Equ. To Paroxetine Excipients Approved Colour used IP 20mg q.s
460 Paroxetine Prolonged Release tablet Each enteric?oated Bilayered prolonged release Tablet contains : Paroxetine Hydrochloride (as Hemihydrate) Equ. To Paroxetine Excipients Approved colour used IP 12.5mg q.s
461 Paroxetine Prolonged- Release Tablets IP Each enteric coated prolonged-release tablet contains: Paroxetine Hydrochloride Hemihydrate Eq.to Paroxetine Excipients Approved colour used IP 12.5mg
462 Phenylephrine Hydrochloride and Chlorpheniramine MaleateDrops IP Each ml contains : Phenylephrine Hydrochloride Chlorpheniramine Maleate In a flavoured syrupyBase.Approved colour used. IP IP 5mg 2mg q.s.
463 Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, Cetirizine Hydrochloride, Ambroxol Hydrochloride, Guaiphenesin Tablets Each uncoated Tablet Contains : Phenylephrine Hydrochloride Dextromethorphan Hydrochloride Cetirizine Hydrochloride Ambroxol Hydrochloride Guaiphenesin Excipients Approved colour used. IP IP IP IP IP 15mg 10mg 5mg 30mg 100mg q.s.
464 Phenytoin Tablets IP Each film coated tablet contains:- Phenytoin Sodium Excipients Colour : Approved Coloured Used IP 100 mg q.s.
465 Piracetam & CiticolineTablet s Each film coatedtablet contain: Piracetam Citicoline Sodium Eq. to Citicoline Excipients Approved colour used IP IP 400 mg 500 mg q.s.
466 Piracetam Tablets Each film coated tablet contains: Piracetam Excipients Approved colour used IP 800 mg q.s.
467 Piracetam Tablets IP Each film coatedtablet contain: Piracetam Excipients Approved colour used IP 400 mg q.s.
468 Piroxicame DispersibleTablets Each uncoated dispersible tablet contains: Piroxicame Excipients Approved colour used IP 20 mg q.s.
469 Potassium Citrate, Magnesium Citrate & Vitamin B6 Oral Solution Each 5ml contains : Potassium Citrate Magnesium Citrate Pyridoxine Hydrochloride In a Flavoured SyrupyBase Approved colour used IP USP IP 1100mg 375mg 20mg q.s.
470 Povidone Iodine Germicide Gargle Composition: Povidone Iodine (0.2%w/v Available Iodine) Absolute alcohol contain In a mint Flavour aqueous base IP 2.0% w/v 8.38% v/v q.s.
471 Povidone Iodine Solution IP Composition : Povidone Iodine (available Iodine0.5%w/v) Purified Water IP IP 5%w/v q.s
472 Prasugrel Hydrochloride Tablets Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. To Prasugrel Excipients Approved colour used. 5mg q.s.
473 Prasugrel Hydrochloride Tablets Each Film coated Tablet Contains : Prasugrel Hydrochloride Equ. To Prasugrel Excipients Approved colour used. 10mg q.s.
474 Prazosin Tablets IP Each uncoated tablet contains: Prazosin Hydrochloride Eq.to Prazosin Excipients Approved colour used. IP 5mg q.s.
475 Prednisolone Tablet IP Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used IP 5mg q.s
476 Prednisolone Tablet IP Each uncoated Tablet contains: Prednisolone Excipients Colour : Approved Coloured Used IP 10mg q.s
477 Prednisolone Tablet IP Each uncoated Tablet contains Prednisolone Excipients Colour : Approved Coloured Used IP 20mg q.s
478 Pregabalin (SR), Methylcobalamin & Nortriptyline Tablets Each film coated Tablet Contains: Nortriptyline Hydrochloride Equivalent to Nortriptyline Pregabalin (as Sustained Release) Methylcobalamin Excipient Approved colour used IP IP IP 10 mg 75 mg 1500mcg q.s.
479 Pregabalin (Sustained Release) & Methylcobalamin Tablets Each film coated Bilayered Tablet Contains: Pregabalin ( As Sustained Release) Methylcobalamin Excipients Approved Colour Used. IP IP 75mg 1500mcg q.s.
480 Pregabalin Sustained Release Tablet Each Uncoated Sustained Release Tablet Contains : Pregabalin Excipients Approved colour used IP 75mg q.s.
481 Pregabalin, Methylcobalamin, Alpha Lipoic Acid, Folic acid & Pyridoxine Tablets Each film coated Tablet contains : Pregabalin Methylcobalamin Alpha Lipoic Acid Folic Acid Pyridoxine hydrochloride Excipients Approved colour used IP IP USP IP IP 75mg 1500mcg 100mg 1.5mg 3mg q.s
482 Pregabalin( Sustained Release) & Methylcobalamin Tablets Each film coated Tablet Contains: Pregabalin ( As Sustained Release) Methylcobalamin Excipients Approved Colour Used. IP IP 75mg 1500mcg q.s.
483 Prochlorperazine Maleate Mouth Dissolving Tablets Each uncoated Tablet contains: Prochlorperazine Maleate Excipients IP 5mg q.s.
484 Propranolol Hydrochloride (SR) & Flunarizine Tablets Each Uncoated Bilayered Tablet Contains: Propranolol Hydrochloride (as Sustained Release) Flunarizine Dihydrochloride Equ. To Flunarizine Excipients Approved colour used. IP BP 40mg 10mg q.s.
485 Propranolol Hydrochloride Tablets Each Uncoated Tablet Contains: Propranolol Hydrochloride Excipients IP 40mg q.s.
486 Protein Hydrolysate, Calcium, Phosphorus, Vitamin B6, Cyanocobalamin Vitamin D3, Niacinamide, Folic Acid, Zinc & Iron Each 30g contains: Protein hydrolysate 20% Calcium (as Dibasic Calcium Phosphate) Phosphorus (as Dibasic Calcium Phosphate) Vitamin B6 (Pyridoxine Hydrochloride) Vitamin B12 (Cyanocobalamin) Vitamin D3 Niacinamide Folic Acid Zinc (as ZincSulphate Heptahydrate IP) Iron (as Ferric Ammonium Citrate IP) Excipients IP IP IP IP IP IP IP 5 g 225 mg 174 mg 0.5 mg 1 mcg 100 IU 15 mg 300 mg 5 mg 7.5 mg q.s.
487 Prulifloxacin Tablets Each film coated Tablet Contains: Prulifloxacin Excipients Approved Colour used 600mg
488 Pyridoxine Hydrochloride Tablets IP Each uncoated Tablet Contains: Pyridoxine Hydrochloride Excipients IP 50mg q.s.
489 Rabeprazole & Domperidone Tablets Each enteric coated tablets contains: Rabeprazole Sodium Domperidone Excipients Colour:- Approved colour used IP IP 20 mg 10 mg q.s
490 Rabeprazole Gastro- Resistant Tablets IP Each enteric coated tablets contains: Rabeprazole Sodium Excipients Colour:- Approved colour used IP 20mg q.s
491 Ramipril & Hydrochlorothiazid e Tablets IP Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used IP IP 2.5mg 12.5mg q.s.
492 Ramipril & Hydrochlorothiazid e Tablets IP Each uncoated Tablet Contains: Ramipril Hydrochlorthiazide Excipients Approved colour used IP IP 5mg 12.5mg q.s.
493 Ramipril Tablets IP Each Uncoated Tablet Contains: Ramipril Excipients IP 2.5mg q.s.
494 Ramipril Tablets IP Each uncoated Tablet Contains: Ramipril Excipients Approved colour used IP 1.25 mg q.s.
495 Ramipril Tablets IP Each uncoated Tablet Contains: Ramipril Excipients Approved colour used IP 5mg q.s.
496 Ranitidine Hydrochloride Tablets Each film coated Tablet contains: Ranitidine Hydrochloride Equ. To Ranitidine Excipients Approved colour used. IP 150mg q.s
497 Ranitidine Hydrochloride Tablets Each film coated Tablet contains: Ranitidine Hydrochloride Equ. To Ranitidine Excipients Approved colour used. IP 300mg q.s
498 Riboflavin , Folic Acid, Niacinamide & Lactic Acid Bacillus Tablets Each Uncoated Tablet contains: Riboflavin Folic acid Niacinamide Lacticacid bacillus Excipients Colour: Tartrazine IP IP IP 10mg 1.5mg 100mg 60Million Spores q.s
499 Riboflavin, Folic Acid, Niacinamide with Lactic Acid Bacillus Tablets Each uncoated Tablet Contains: Riboflavin Folic Acid Niacinamide Lactic Acid Bacillus Excipients Approved colour used. IP IP IP 10mg 1.5mg 50mg 120 Million spores q.s.
500 Rifaximin Tablets Each film coatedtablets contains: Rifaximin Excipients Approved colour used 550 mg q.s.
501 Rifaximin Tablets Each film coated tablets contains: Rifaximin Excipients Approved colour used 400 mg q.s.
502 Rifaximine Tablets Each film coated tablets contains: Rifaximine Excipients Approved colour used 200 mg q.s.
503 Rosuvastatin & FenofibrateTablets Each film coated Tablet Contains: Rosuvastatin Calcium Equ. To Rosuvastatin Fenofibrate Excipients Approved colour used IP IP 20mg 160mg q.s.
504 Rosuvastatin & FinofibrateTablet IP Each film coated tablet contains:- Rosuvastatin calcium Equ. to Rosuvastatin Finofibrate Excipients Colour : Approved Coloured Used IP IP 10mg 160mg q.s.
505 Rosuvastatin Tablet IP Each film coated tablet Contains : Rosuvastatin Calcium Equ. To Rosuvastatin Excipients Approved Colour Used IP 40mg
506 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used IP 5 mg q.s.
507 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin calcium Eq.to Rosuvastatin Excipients Approved colour used IP 10 mg q.s.
508 Rosuvastatin Tablets IP Each filmcoated tablet contain Rosuvastatin Calcium Eq.to Rosuvastatin Excipients Approved colour used IP 20 mg q.s.
509 Roxithromycin & Ambroxol Tablets Each film coatedtablet contain: Roxithromycin Ambroxol Hydrochloride Excipients Approved colour used IP IP 150 mg 60 mg q.s
510 Roxithromycin Tablets Each film coated tablets contains: Roxithromycin Excipients Approved colour used IP 150 mg q.s.
511 Serratiopeptidase tablet IP Each film coated tablet Contains :- Serratiopeptidase (Equ. to Enzyme activity20,000Units of enteric coated granules) Excipients Colour : Approved Colour Used IP 10mg q.s.
512 Sertraline Hydrochloride Tablets IP Each film coated Tablet Contains: Sertraline Hydrochloride Equ. To Sertraline Excipients Approved Colour used. IP 50mg q.s.
513 Sertraline Tablets IP Each film coated tablets contains: Sertraline Hydrochloride Eq. to Sertraline Excipients Approved colour used. IP 25mg q.s.
514 Sevelamer CarbonateTablets Each film coated Tablet Contains: Sevelamer Carbonate Excipients Approved colour used 400mg q.s.
515 Sildenafil Citrate Tablets IP Each film coated tablet contains:- Sildenafil Citrate Eq. to sildenafil Excipients Colour:- Approved Colour used IP 50 mg q.s.
516 Sildenafil Citrate Tablets IP Each film coated tablet contains:- Sildenafil Citrate Eq. to sildenafil Excipients Colour:- Approved Colour used IP 100 mg q.s.
517 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin Metformin Hydrochloride Excipients Approved colour used. IP 64.25mg 50mg 500mg q.s.
518 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablets contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin Metformin Hydrochloride Excipients Approved colour used IP 64.25mg 50mg 1000mg q.s.
519 Sitagliptin Phosphate & Metformin Hydrochloride Tablets Each film coated Tablet Contains : Sitagliptin Phosphate Monohydrate Equ. To Sitagliptin Metformin Hydrochloride Excipients Approved colour used. IP IP 64.25mg 50mg 850mg q.s.
520 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin Excipients Approved Colour used IP 25mg q.s
521 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin Excipients Approved Colour used IP 50mg q.s
522 Sitagliptin PhosphateTablet Each film coated Tablet Contains : Sitagliptin phosphate Monohydrate Equ. To Sitagliptin Excipients Approved Colour used IP 100mg q.s
523 Sodium Valproate & Valproic Acid Controlled ReleaseTablet Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used IP IP 133.5 mg 58 mg 200 mg q.s.
524 Sodium Valproate & Valproic Acid Controlled ReleaseTablet Each film coated controlledrelease tablet contains: Sodium Valproate Valproic Acid (Both together correspond tosodium valproate) Excipients Approved colour used IP IP 333 mg 145 mg 500 mg q.s.
525 Solifenacin Succinate Tablets IP Each film coated tablet contains: Solifenacin Succinate Excipients Approved colour used. IP 5mg q.s.
526 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 25mg q.s.
527 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 50mg q.s.
528 Spironolactone Tablets IP Each Uncoated Tablet Contains: Spironolactone Excipients Approved colour used IP 100mg q.s.
529 Sulfasalazine Gastro ?Resistant Tablets IP Each enteric coated tablet contains: Sulfasalazine Excipients Approved colour used. IP 500mg q.s.
530 Sulfasalazine Gastro Resistant Tablets USP Each Enteric Coated Tablet Contains: Sulfasalazine Excipients Approved colour used USP 1000mg q.s.
531 Tadalafil Tablet IP Each uncoated tablet contains: Tadalafil Excipients Approved colour used IP 10 mg q.s
532 Tadalafil Tablet IP Each uncoated tablet contains: Tadalafil Excipients Approved colour used IP 20 mg q.s
533 Tamsulosin Hydrochloride (MR) & Dutasteride Tablets Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Dutasteride Excipients Approved colour used. IP IP 0.4 mg 0.5 mg q.s.
534 Tamsulosin Hydrochloride Modified Release Tablets Each film coated Tablet contains: Tamsulosin Hydrochloride (as modified release) Excipients Approved colour used. IP 0.4mg q.s.
535 Tapentadol Tablets Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used IP 50 mg q.s.
536 Tapentadol Tablets Each film coatedtablet contain: Tapentadol Hydrochloride Equivalent to Tapentadol Excipients Approved colour used IP 100 mg q.s.
537 Telmisartan & AmlodipineTablets Each uncoated Bilayered Tablet Contains: Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved colour used. IP IP 80mg 5mg q.s.
538 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used. IP IP 40mg 5mg q.s.
539 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine "Excipients Colour: Approved Coloured Used. IP IP 80mg 10mg q.s
540 Telmisartan & AmlodipineTablets IP Each Uncoated Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Approved Colour Used. IP IP 80mg 5mg q.s.
541 Telmisartan & AmlodipineTablets IP Each Uncoated Bilayered Tablet Contains :- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Colour Used. IP IP 40mg 5mg q.s.
542 Telmisartan & AmlodipineTablets IP Each Uncoated Bilayered Tablet Contains:- Telmisartan Amlodipine Besylate Equ. To Amlodipine Excipients Colour: Approved Coloured Used. IP IP 80mg 10mg q.s
543 Telmisartan & Atorvastatin Tablets Each film coated Tablet Contains : Telmisartan Atorvastatin Calcium Equ. To Atorvastatin. Excipients Approved colour used. IP IP 40mg 10mg q.s.
544 Telmisartan & Chlorthalidone Tablets Each uncoated Bilayered Tablet contains: Telmisartan Chlorthalidone Excipients Approved colour used. IP IP 40mg 12.5mg q.s.
545 Telmisartan & CilnidipineTablets Each Film coated Tablet Contains : Telmisartan Cilnidipine Excipients Approved colour used. IP IP 40mg 10mg q.s.
546 Telmisartan & Hydrochlorthiazide Tablet IP Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: Approved Coloured Used. IP IP 80mg 12.5mg q.s
547 Telmisartan & Metoprolol Succinate (ER) Tablets Each uncoated bilayer tablet contain: Telmisartan Metoprolol Succinate Eq. to Metoprolol Tartrate (As Extended Release) Excipients Approved colour used IP IP 40 mg 47.5 mg 50 mg q.s.
548 Telmisartan & Metoprolol Succinate (ER) Tablets Each Uncoated Bilayered Tablet Contains: Telmisartan Metoprolol Succinate Equ. To Metoprolol Tartrate(as Extended Release ) Excipients Approved colour used IP IP IP 40mg 23.75 25mg q.s.
549 Telmisartan and Hydrochlorothiazid e Tablets IP Each Uncoated Tablet Contains:- Telmisartan Hydrochlorothiazide Excipients Colour: Approved Colour Used. IP IP 40mg 12.5mg q.s.
550 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 20mg q.s
551 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 40mg q.s
552 Telmisartan Tablet IP Each Uncoated Tablet Contains:- Telmisartan Excipients Colour: Approved Colour Used. IP 80mg q.s
553 Telmisartan, Amlodipine & Hydrochlorothiazid e Each uncoated bilayer tablet contain: Telmisartan Amlodipine Besylate Eq.to Amlodipine Hydrochlorothiazide Excipients Approved colour used IP IP IP 40 mg 5 mg 12.5 mg
554 Teneligliptin & Metformin hydrochloride Tablets Each uncoated by-layered tablets contains: Teneligliptin hydrobromide hydrat Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used IP 20 mg 500 mg q.s.
555 Teneligliptin & Metformin Hydrochloride Tablets Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide hydrate Equivalent to Teneligliptin Metformin hydrochloride (As Extended release) Excipients Approved colour used IP 20 mg 1000 mg q.s.
556 Terbinafine hydrochloride Tablets IP Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used IP 250 mg q.s.
557 Terbinafine hydrochloride Tablets IP Each film coated tablets contains: Terbinafine hydrochloride Equivalent to Terbinafine Excipients Approved colour used IP 500 mg q.s.
558 Terbutaline Sulphate, Ambroxol HCl, Guaiphenesin & Menthol Expectorant Each 5ml contains : Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Menthol Flavoured SyrupyBase Approved colour used. IP IP IP IP 1.5mg 15mg 50mg 1.5mg q.s.
559 Thiamine Hydrochloride Tablets IP Each film coated Tablet Contains: Thiamine Hydrochloride Excipients Approved colour used IP 100mg q.s.
560 Thiamine Tablets IP Each uncoated Tablet Contains Thiamine Hydrochloride Excipients Colour :- Approved colour used IP 50mg q.s
561 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 12.5mcg q.s
562 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 25mcg q.s
563 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 50mcg q.s
564 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 75mcg q.s
565 Thyroxine Tablet IP Each Uncoated Tablet Contains Thyroxine sodium (as anhydrous) Excipients Colour : Approved Coloured Used IP 100 mcg q.s
566 Ticagrelor Tablets Each film coated tablet contains: Ticagrelor Excipients Approved colour used IP 90mg q.s
567 Tolperisone Hydrochloride & Diclofenac Sodium Tablets Each Film coated Tablets Contains : Tolperisone Hydrochloride Diclofenac Sodium Excipients Approved colour used JP IP 150mg 50mg q.s.
568 Tolperisone Hydrochloride & Paracetamol Tablet Each film coated Tablet Contains: Tolperisone hydrochloride Paracetamol Excipients Approved colour Used JP IP 150mg 325mg
569 Tolperisone Hydrochloride Sustained Release Tablet Each film coated sustained Release Tablet Contains: Tolperisone Hydrochloride Excipients Approved Colour Used JP 450mg
570 Tolperisone Hydrochloride Tablet Each film coated Tablet Contains: Tolperisone Hydrochloride Excipients Approved colour used JP 150mg q.s
571 Torsemide & Spironolactone Tablets Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used IP IP 10 mg 50 mg q.s.
572 Torsemide & Spironolactone Tablets Each uncoated tablet contain: Torsemide Spironolactone Excipients Approved colour used IP IP 20 mg 50 mg q.s.
573 Torsemide & Spironolactone Tablets Each uncoated tablet contains: Torsemide Spironolactone Excipients Approved colour used IP IP q mg 50 mg q.s.
574 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 10 mg q.s.
575 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 20 mg q.s.
576 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 5 mg q.s.
577 Torsemide Tablets IP Each uncoated tablet contain: Torsemide Excipients Approved colour used IP 100 mg q.s.
578 Tramadol Hydrochloride Prolonged Release Tablet IP Each film coated sustainedrelease tablet contain: Tramadol Hydrochloride Excipients Approved colour used IP 100mg q.s
579 Tramadol Hydrochloride Tablet IP Each film coatedtablet contain: Tramadol Hydrochloride Excipients Approved colour used IP 100mg q.s
580 Tranexamic Acid & Ethamsylate Tablets Each film coated Tablet contains: Tranexamic Acid Ethamsylate Excipients Approved colour used. IP BP 250mg 250mg q.s.
581 Tranexamic Acid & Mefenamic Acid Tablets Each film coated tablets contains: Tranexamic Acid Mefenamic Acid Excipients Approved colour used IP IP 500 mg 250 mg q.s.
582 Tranexamic Acid Tablets IP Each film coated Tablet Contains: Tranexamic Acid Excipients Approved Colour Used. IP 500mg
583 Tranexamic Acid Tablets IP (Correctain done in new Permission 18/12/2024) Each film coated Tablet Contains: Tranexamic Acid Excipients Colour : Approved Coloured Used IP 250mg q.s
584 Trifluoperazine Hydrochloride Tablets IP Each film coated Tablet contains: Trifluoperazine Hydrochloride Excipients Approved colour used IP 5mg q.s
585 Trypsin , Bromelain and Rutoside Trihydrate Tablets Each Enteric coated tablet contains: Trypsin Bromelain RutosideTrihydrate Excipients Approved colour used. BP BP 96mg 180mg 200mg q.s.
586 Trypsin ?Chymotrypsin Tablets Each enteric ?coated tablet contains: 2,00,000 Armour Units of Enzymatic Activity* *Supplied by a purified Concentrate which has Specific Trypsin and Chymotrypsin Activity in a Ratio of Approximately Six to One. Excipients Approved colour used. 2,00,000 AU q.s.
587 Trypsin- Chymotrypsin Tablets Each entericcoated Tablet contains: 1,00,000 Armour units of enzymaticactivity *Supplied by a purified concentrate which has specific Trypsin & Chymotrypsin activityin aratio of Approximately six to one. Excipients Approved colour used." q.s.
588 Trypsin-Chymotrypsin, Aceclofenac & Paracetamol Tablets Each film coated tablet contains: Aceclofenac Paracetamol Trypsin-Chymotrypsin Of enzyme activity (as enteric coated granules) Excipients Approved colour used. IP IP 100mg 325mg 150,000AU q.s.
589 Trypsin, Bromelain & Rutoside Trihydrate Tablets Each Enteric coated Tablet Contains:- Trypsin Bromelain RutosideTrihydrate Equivalent to Rutoside (anhydrous) Excipients Approved colour used BP BP 48 mg 90 mg 100 mg q.s.
590 Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets Each Enteric coated Tablet Contains : Trypsin Bromelain Rutoside Trihydrate Diclofenac Sodium Excipients Approved Colour Used. BP BP IP 48mg 90mg 100mg 50mg q.s.
591 Trypsin, Bromelain, Rutoside Trihydrate and Aceclofenac Tablets Each enteric coated Tablet contains : Trypsin Bromelain Rutoside Trihydrate "Aceclofenac Excipients Approved colour used" IP BP IP 48mg 90mg 100mg 100mg q.s
592 Ursodeoxycholic Acid Tablets IP Each film coated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used IP 300 mg q.s.
593 Ursodeoxycholic Acid Tablets IP Each film coated tablets contains: Ursodeoxycholic Acid Excipients Approved colour used IP 150 mg q.s.
594 Vildagliptin & Metformin Hydrochloride Tablet Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used IP 50 mg 500 mg q.s.
595 Vildagliptin & Metformin Hydrochloride Tablet Each film coated tablet contains: Vildagliptin Metformin Hydrochloride Excipients Approved colour used IP 50 mg 1000 mg q.s.
596 Vildagliptin Tablet Each uncoated tablet contains: Vildagliptin Excipients Approved colour used 50 mg q.s.
597 Vitamin D3 oral solution Each 5 ml contains: Cholecalciferol (In Nano Droplet form) In a flavoured sugar free syrupybase. Approved colour used. IP 60000IU q.s
598 Vitamin E Acetate & Levocarnitine Tablets Each film coated tablet contains: Tocopheryl Acetate (as 50% powder) L- Carnitine ? ?Tartrate Eq. to Levocarnitine Appropriate overages added Excipients Approved colour used. IP USP 200mg 150mg q.s
599 Voglibose & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP 0.2 mg 500 mg q.s.
600 Voglibose & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP 0.3 mg 500mg q.s.
601 Voglibose Dispersible Tablet IP Each uncoated tablet contains: Voglibose Excipients Approved colour used IP 0.2 mg q.s.
602 Voglibose Dispersible Tablet IP Each uncoated tablet contains: Voglibose Excipients Approved colour used IP 0.3 mg q.s.
603 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.2 mg 1 mg 500mg q.s.
604 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.2 mg 2 mg 500mg q.s.
605 Voglibose, Glimepiride & Metformin Hydrochloride (Sustained Release) Tablet Each uncoated Bilayered tablet contains: Voglibose Glimepiride Metformin Hydrochloride (As Sustained Release) Excipients Approved colour used IP IP IP 0.3 mg 2 mg 500mg q.s.
606 Voriconazole Tablet IP Each film coated Tablet Contains: Voriconazole Excipients Approved Colour Used. IP 200 mg q.s
607 Warfarin Sodium Tablets IP 1mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used IP 1mg q.s.
608 Warfarin Sodium Tablets IP 3mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used IP 3mg q.s.
609 Warfarin Sodium Tablets IP 5mg Each uncoated tablet contains: Warfarin Sodium Clathrate Eq. to Warfarin Sodium (anhydrous) Excipients Approved Colour used IP 5mg q.s.
610 Zinc Acetate Tablets Each Entericcoated Tablet Contains: Zinc Acetate(as 65ehydrate) Equ. toElemental Zinc Excipients Approved Colour Used USP 50mg q.s
Call Us Whatsapp Send Query